| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | small GTPase binding | MYO5A DOCK11 MYO9B CDKL5 CYFIP1 RABGEF1 TBC1D21 ROCK2 MICAL1 DOCK10 DNM1L CYFIP2 ARHGAP1 APPL2 RASSF1 DOCK7 FGD6 XPOT XPO7 | 1.36e-07 | 321 | 278 | 19 | GO:0031267 |
| GeneOntologyMolecularFunction | GTPase binding | MYO5A DOCK11 MYO9B CDKL5 CYFIP1 RABGEF1 TBC1D21 ROCK2 MICAL1 DOCK10 DNM1L CYFIP2 ARHGAP1 APPL2 RASSF1 DOCK7 FGD6 XPOT XPO7 | 7.84e-07 | 360 | 278 | 19 | GO:0051020 |
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 2.67e-06 | 3 | 278 | 3 | GO:0008184 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK11 MYO9B CYTH3 GBP1 GBP3 ARHGEF11 RABGEF1 ARHGEF37 ARHGAP20 DOCK6 TBC1D21 TBCD IQSEC3 DOCK10 DNM1L KRIT1 ARHGAP1 DENND6A TBCK DOCK7 FGD6 | 9.51e-06 | 507 | 278 | 21 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK11 MYO9B CYTH3 GBP1 GBP3 ARHGEF11 RABGEF1 ARHGEF37 ARHGAP20 DOCK6 TBC1D21 TBCD IQSEC3 DOCK10 DNM1L KRIT1 ARHGAP1 DENND6A TBCK DOCK7 FGD6 | 9.51e-06 | 507 | 278 | 21 | GO:0030695 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYO9B MCM7 ATP8B1 SMC5 LONP1 DDX46 KIF2B KIF28P HFM1 ASCC3 MOV10 RAD17 DDX49 DNAH10 RNF213 ATP2B1 ATP2B2 ATP2B4 DNAH11 | 1.48e-05 | 441 | 278 | 19 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO5A MYO9B MCM7 ATP8B1 SMC5 DNAH14 LONP1 DDX46 KIF2B KIF28P HFM1 ASCC3 MOV10 RAD17 DDX49 EP400 DNAH10 RNF213 ATP2B1 ATP2B2 ATP2B4 TOP2B DNAH11 | 1.80e-05 | 614 | 278 | 23 | GO:0140657 |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 2.62e-05 | 5 | 278 | 3 | GO:0004645 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYO9B GBP1 GBP3 MCM7 ATP8B1 SMC5 LONP1 DDX46 KIF2B KIF28P HFM1 ASCC3 MOV10 RAD17 DDX49 DNAH10 RNF213 DNM1L RIT2 ATP2B1 ATP2B2 ATP2B4 DIRAS2 MX1 DNAH11 | 8.99e-05 | 775 | 278 | 25 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYO9B GBP1 GBP3 MCM7 ATP8B1 SMC5 LONP1 DDX46 KIF2B KIF28P HFM1 ASCC3 MOV10 RAD17 DDX49 DNAH10 RNF213 DNM1L THTPA RIT2 ATP2B1 ATP2B2 ATP2B4 DIRAS2 MX1 DNAH11 | 1.24e-04 | 839 | 278 | 26 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYO9B GBP1 GBP3 MCM7 ATP8B1 SMC5 LONP1 DDX46 KIF2B KIF28P HFM1 ASCC3 MOV10 RAD17 DDX49 DNAH10 RNF213 DNM1L THTPA RIT2 ATP2B1 ATP2B2 ATP2B4 DIRAS2 MX1 DNAH11 | 1.26e-04 | 840 | 278 | 26 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYO9B GBP1 GBP3 MCM7 ATP8B1 SMC5 LONP1 DDX46 KIF2B KIF28P HFM1 ASCC3 MOV10 RAD17 DDX49 DNAH10 RNF213 DNM1L THTPA RIT2 ATP2B1 ATP2B2 ATP2B4 DIRAS2 MX1 DNAH11 | 1.26e-04 | 840 | 278 | 26 | GO:0016818 |
| GeneOntologyMolecularFunction | calcium ion binding | EFCAB5 MYO5A ADGRL4 ITPR3 STIM1 FAT1 PCDHB1 PCDHGB7 PCDHGB5 PCDHGB2 FAT3 PCDH11Y PCDHB10 PCDHB9 PCDHAC1 MYOF P4HTM MCTP1 LPL ATP2B2 CDH6 CDH8 CDH12 CDH13 | 1.38e-04 | 749 | 278 | 24 | GO:0005509 |
| GeneOntologyMolecularFunction | histone H3K36 demethylase activity | 4.05e-04 | 11 | 278 | 3 | GO:0051864 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 4.05e-04 | 11 | 278 | 3 | GO:0005388 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | DOCK11 CYTH3 ARHGEF11 RABGEF1 ARHGEF37 DOCK6 IQSEC3 DOCK10 DENND6A DOCK7 FGD6 | 4.14e-04 | 231 | 278 | 11 | GO:0005085 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | SLITRK1 FAT1 SLITRK2 PCDHB1 PCDHGB7 PCDHGB5 PCDHGB2 FAT3 L1CAM PCDH11Y PCDHB10 PCDHB9 PCDHAC1 SLITRK3 TGFB2 TNFAIP3 MDGA1 CDH6 CDH8 CDH12 CDH13 | 1.33e-09 | 313 | 273 | 21 | GO:0098742 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | FAT1 PCDHB1 PCDHGB7 PCDHGB5 PCDHGB2 FAT3 L1CAM PCDH11Y PCDHB10 PCDHB9 PCDHAC1 CDH6 CDH8 CDH12 CDH13 | 3.07e-08 | 187 | 273 | 15 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell junction organization | MYO5A ZNF804A SLITRK1 CHRNA7 CDKL5 NLGN3 SLITRK2 CYFIP1 MMP14 CHRFAM7A TBCD ROCK2 IQSEC3 ANK2 LRRN1 VEZT L1CAM PCDHB10 PCDHB9 DOCK10 LAMA3 DNM1L SLITRK3 CYFIP2 TGFB2 VPS35 DOCK7 TANC1 MDGA1 ATP2B2 CDH6 CDH8 CDH12 CDH13 | 2.51e-07 | 974 | 273 | 34 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell morphogenesis | MYO9B IMPACT MGLL SLITRK1 CHRNA7 CDKL5 NLGN3 FAT1 SLITRK2 CYFIP1 KIDINS220 KEL CHRFAM7A MOV10 TBCD ROCK2 FAT3 L1CAM SMURF1 DOCK10 LAMA3 DNM1L SLITRK3 CYFIP2 TGFB2 FAM171A1 FEZF1 TET1 DOCK7 TRAK2 FGD6 ATP2B2 CDH6 CDH8 CDH12 TOP2B CUX1 CDH13 | 4.75e-07 | 1194 | 273 | 38 | GO:0000902 |
| GeneOntologyBiologicalProcess | synapse organization | MYO5A ZNF804A SLITRK1 CHRNA7 CDKL5 NLGN3 SLITRK2 CYFIP1 CHRFAM7A ROCK2 IQSEC3 LRRN1 VEZT L1CAM PCDHB10 PCDHB9 DOCK10 DNM1L SLITRK3 CYFIP2 VPS35 DOCK7 TANC1 MDGA1 ATP2B2 CDH6 CDH8 | 4.75e-07 | 685 | 273 | 27 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | MGLL SLITRK1 CHRNA7 CDKL5 NLGN3 SLITRK2 CYFIP1 KIDINS220 KEL CHRFAM7A TBCD ROCK2 FAT3 L1CAM SMURF1 DOCK10 LAMA3 DNM1L SLITRK3 CYFIP2 TGFB2 FEZF1 TET1 DOCK7 TRAK2 ATP2B2 TOP2B CUX1 | 8.06e-07 | 748 | 273 | 28 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of synapse organization | ZNF804A SLITRK1 CHRNA7 CDKL5 NLGN3 SLITRK2 CYFIP1 CHRFAM7A ROCK2 LRRN1 L1CAM DOCK10 DNM1L SLITRK3 CYFIP2 VPS35 TANC1 MDGA1 CDH8 | 1.09e-06 | 387 | 273 | 19 | GO:0050807 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | ZNF804A SLITRK1 CHRNA7 CDKL5 NLGN3 SLITRK2 CYFIP1 CHRFAM7A ROCK2 LRRN1 L1CAM DOCK10 DNM1L SLITRK3 CYFIP2 VPS35 TANC1 MDGA1 CDH8 | 1.48e-06 | 395 | 273 | 19 | GO:0050803 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | MYO9B IMPACT MGLL SLITRK1 CHRNA7 CDKL5 NLGN3 SLITRK2 CYFIP1 KIDINS220 KEL CHRFAM7A MOV10 ROCK2 L1CAM SMURF1 DOCK10 LAMA3 DNM1L SLITRK3 CYFIP2 TGFB2 FEZF1 TET1 DOCK7 TRAK2 TOP2B CUX1 | 4.62e-06 | 819 | 273 | 28 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | MYO9B IMPACT MGLL SLITRK1 CHRNA7 CDKL5 NLGN3 SLITRK2 CYFIP1 KIDINS220 KEL CHRFAM7A MOV10 ROCK2 L1CAM SMURF1 DOCK10 LAMA3 DNM1L SLITRK3 CYFIP2 TGFB2 FEZF1 TET1 DOCK7 TRAK2 TOP2B CUX1 | 5.42e-06 | 826 | 273 | 28 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell junction assembly | SLITRK1 NLGN3 SLITRK2 MMP14 TBCD ROCK2 ANK2 LRRN1 L1CAM PCDHB10 PCDHB9 DOCK10 LAMA3 SLITRK3 CYFIP2 VPS35 DOCK7 MDGA1 CDH6 CDH8 CDH12 CDH13 | 7.76e-06 | 569 | 273 | 22 | GO:0034329 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | IMPACT MGLL SLITRK1 CHRNA7 CDKL5 NLGN3 SLITRK2 CYFIP1 KIDINS220 KEL CHRFAM7A MOV10 ROCK2 L1CAM SMURF1 DOCK10 LAMA3 DNM1L SLITRK3 CYFIP2 TGFB2 FEZF1 TET1 DOCK7 TRAK2 TOP2B CUX1 | 9.11e-06 | 802 | 273 | 27 | GO:0048812 |
| GeneOntologyBiologicalProcess | neuron projection development | GAK INPPL1 IMPACT MGLL ZNF804A SLITRK1 CHRNA7 CDKL5 NLGN3 SLITRK2 CYFIP1 SERPINI1 KIDINS220 KEL CHRFAM7A MOV10 ROCK2 FAT3 L1CAM SMURF1 DOCK10 LAMA3 DNM1L SLITRK3 SHOC2 CYFIP2 RIT2 TGFB2 FEZF1 TET1 DOCK7 TRAK2 ATP2B2 SF3A2 TOP2B CUX1 | 1.71e-05 | 1285 | 273 | 36 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of presynapse organization | 3.06e-05 | 46 | 273 | 6 | GO:0099174 | |
| GeneOntologyBiologicalProcess | neuron development | GAK INPPL1 IMPACT MGLL ATP8B1 ZNF804A SLITRK1 CHRNA7 CDKL5 NLGN3 SLITRK2 CYFIP1 SERPINI1 KIDINS220 KEL CHRFAM7A MOV10 TBCD ROCK2 FAT3 L1CAM SMURF1 DOCK10 LAMA3 DNM1L SLITRK3 SHOC2 CYFIP2 RIT2 TGFB2 FEZF1 TET1 DOCK7 TRAK2 ATP2B2 SF3A2 TOP2B CUX1 | 5.11e-05 | 1463 | 273 | 38 | GO:0048666 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 6.93e-05 | 53 | 273 | 6 | GO:0016339 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | CHRNA7 CDKL5 NLGN3 KIDINS220 CHRFAM7A ROCK2 DOCK10 DNM1L TET1 TRAK2 CUX1 | 6.98e-05 | 198 | 273 | 11 | GO:0048813 |
| GeneOntologyBiologicalProcess | postsynapse organization | ZNF804A CHRNA7 CDKL5 NLGN3 CHRFAM7A ROCK2 IQSEC3 DOCK10 DNM1L SLITRK3 CYFIP2 VPS35 DOCK7 TANC1 | 7.95e-05 | 313 | 273 | 14 | GO:0099173 |
| GeneOntologyBiologicalProcess | regulation of mitochondrial fission | 1.06e-04 | 36 | 273 | 5 | GO:0090140 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | DOCK11 MYO9B CYTH3 ARHGEF11 CYFIP1 RABGEF1 ARHGAP20 DOCK6 ROCK2 IQSEC3 DOCK10 SHOC2 KRIT1 RIT2 TGFB2 ARHGAP1 RASSF1 DOCK7 CDH13 | 1.09e-04 | 538 | 273 | 19 | GO:0007264 |
| GeneOntologyBiologicalProcess | microtubule-based movement | RSPH14 ARMC3 MYO5A DNAAF11 CHRNA7 DNAH14 KIF2B KIF28P RABGEF1 TBC1D21 CHRFAM7A DNAH10 NPHP3 TRAK2 CFAP69 BBS12 ATP2B4 DNAH11 | 1.09e-04 | 493 | 273 | 18 | GO:0007018 |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | RSPH14 ARMC3 DNAAF11 CHRNA7 DNAH14 TBC1D21 CHRFAM7A DNAH10 CFAP69 ATP2B4 DNAH11 | 1.18e-04 | 210 | 273 | 11 | GO:0060294 |
| GeneOntologyBiologicalProcess | presynapse assembly | 1.40e-04 | 60 | 273 | 6 | GO:0099054 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | RSPH14 ARMC3 DNAAF11 CHRNA7 DNAH14 TBC1D21 CHRFAM7A DNAH10 CFAP69 ATP2B4 DNAH11 | 1.45e-04 | 215 | 273 | 11 | GO:0060285 |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | RSPH14 ARMC3 DNAAF11 CHRNA7 DNAH14 TBC1D21 CHRFAM7A DNAH10 CFAP69 ATP2B4 DNAH11 | 1.45e-04 | 215 | 273 | 11 | GO:0001539 |
| GeneOntologyBiologicalProcess | dendritic spine organization | 1.48e-04 | 115 | 273 | 8 | GO:0097061 | |
| GeneOntologyBiologicalProcess | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 1.75e-04 | 2 | 273 | 2 | GO:0001988 | |
| GeneOntologyBiologicalProcess | terminal button organization | 1.82e-04 | 9 | 273 | 3 | GO:0072553 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial fission | 1.82e-04 | 22 | 273 | 4 | GO:0090141 | |
| GeneOntologyBiologicalProcess | cilium movement | RSPH14 ARMC3 DNAAF11 CHRNA7 DNAH14 TBC1D21 CHRFAM7A DNAH10 NPHP3 CFAP69 ATP2B4 DNAH11 | 1.99e-04 | 261 | 273 | 12 | GO:0003341 |
| GeneOntologyBiologicalProcess | regulation of presynapse assembly | 2.23e-04 | 42 | 273 | 5 | GO:1905606 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 2.23e-04 | 42 | 273 | 5 | GO:0099560 | |
| GeneOntologyBiologicalProcess | synapse assembly | SLITRK1 NLGN3 SLITRK2 LRRN1 L1CAM PCDHB10 PCDHB9 DOCK10 SLITRK3 CYFIP2 VPS35 DOCK7 MDGA1 | 2.51e-04 | 308 | 273 | 13 | GO:0007416 |
| GeneOntologyBiologicalProcess | marginal zone B cell differentiation | 2.57e-04 | 10 | 273 | 3 | GO:0002315 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | SLITRK1 CDKL5 NLGN3 SLITRK2 CYFIP1 PER2 SYNJ1 LRRN1 L1CAM SMURF1 DNM1L SLITRK3 PPARG TG APPL2 FEZF1 DOCK7 TRAK2 MDGA1 CUX1 | 2.67e-04 | 625 | 273 | 20 | GO:0051960 |
| GeneOntologyBiologicalProcess | neuron projection organization | 2.93e-04 | 127 | 273 | 8 | GO:0106027 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | SLITRK1 NLGN3 SLITRK2 LRRN1 L1CAM DOCK10 SLITRK3 CYFIP2 VPS35 MDGA1 | 3.76e-04 | 202 | 273 | 10 | GO:0051963 |
| GeneOntologyBiologicalProcess | regulation of cellular response to insulin stimulus | 3.93e-04 | 101 | 273 | 7 | GO:1900076 | |
| GeneOntologyBiologicalProcess | presynapse organization | 4.12e-04 | 73 | 273 | 6 | GO:0099172 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion mediated by cadherin | 5.10e-04 | 50 | 273 | 5 | GO:0044331 | |
| GeneOntologyBiologicalProcess | baroreceptor response to decreased systemic arterial blood pressure | 5.19e-04 | 3 | 273 | 2 | GO:0001982 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | GAK DOCK11 INPPL1 ATP8B1 ZNF804A SLITRK1 CDKL5 NLGN3 CYFIP1 SERPINI1 KIDINS220 KEL TBC1D21 MOV10 FAT3 L1CAM SMURF1 DNM1L SHOC2 RIT2 VPS35 TRAK2 SF3A2 CUX1 | 5.21e-04 | 863 | 273 | 24 | GO:0031344 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | SLITRK1 NLGN3 FAT1 SLITRK2 PCDHB1 CNN3 PCDHGB7 PCDHGB5 VEZT PCDHGB2 FAT3 L1CAM PCDH11Y PCDHB10 PCDHB9 LAMA3 PCDHAC1 SLITRK3 CYFIP2 TGFB2 DENND6A TNFAIP3 IL1A MDGA1 CDH6 CDH8 CDH12 CDH13 | 5.24e-04 | 1077 | 273 | 28 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | GAK INPPL1 ZNF804A SLITRK1 CDKL5 NLGN3 CYFIP1 SERPINI1 KIDINS220 KEL FAT3 L1CAM SMURF1 DNM1L SHOC2 RIT2 TRAK2 SF3A2 CUX1 | 5.48e-04 | 612 | 273 | 19 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 5.49e-04 | 29 | 273 | 4 | GO:1903779 | |
| GeneOntologyBiologicalProcess | dendrite development | CHRNA7 CDKL5 NLGN3 CYFIP1 KIDINS220 CHRFAM7A ROCK2 FAT3 DOCK10 DNM1L TET1 TRAK2 CUX1 | 5.58e-04 | 335 | 273 | 13 | GO:0016358 |
| GeneOntologyBiologicalProcess | mitochondrial fission | 5.59e-04 | 51 | 273 | 5 | GO:0000266 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | RSPH14 SSX9P SSX6P SSX7 SSX1 SSX5 DNAH14 RSPH10B2 TBC1D21 RSPH10B DNAH10 PCDH11Y SSX3 CFAP69 ATP2B4 DNAH11 | 1.56e-07 | 238 | 281 | 16 | GO:0097729 |
| GeneOntologyCellularComponent | motile cilium | RSPH14 SSX9P SSX6P SSX7 DNAAF11 SSX1 SSX5 DNAH14 RSPH10B2 TBC1D21 RSPH10B DNAH10 PCDH11Y CEP89 SSX3 CFAP69 ATP2B4 DNAH11 | 1.67e-06 | 355 | 281 | 18 | GO:0031514 |
| GeneOntologyCellularComponent | GABA-ergic synapse | SLC6A17 SLITRK1 NLGN3 SLITRK2 IQSEC3 L1CAM SLITRK3 MDGA1 ATP2B1 ATP2B2 CDH13 | 1.42e-05 | 164 | 281 | 11 | GO:0098982 |
| GeneOntologyCellularComponent | catenin complex | 6.34e-05 | 32 | 281 | 5 | GO:0016342 | |
| GeneOntologyCellularComponent | cell leading edge | LAYN MYO5A MYO9B CYTH3 INPPL1 APC2 CHRNA7 CDKL5 FAT1 CYFIP1 AMOTL1 CHRFAM7A VEZT ARHGAP1 APPL2 FGD6 ATP2B1 ATP2B2 | 1.59e-04 | 500 | 281 | 18 | GO:0031252 |
| GeneOntologyCellularComponent | sperm flagellum | RSPH14 SSX9P SSX6P SSX7 SSX1 SSX5 TBC1D21 PCDH11Y SSX3 CFAP69 ATP2B4 | 1.60e-04 | 214 | 281 | 11 | GO:0036126 |
| GeneOntologyCellularComponent | presynapse | GAK MYO5A VPS45 SLC6A17 MGLL ZNF804A CHRNA7 ITPR3 NLGN3 CYFIP1 SYNJ1 CHRFAM7A ROCK2 MICAL1 L1CAM DNM1L MYOF MCTP1 VPS35 TANC1 ATM ATP2B1 ATP2B2 ATP2B4 CDH8 | 4.08e-04 | 886 | 281 | 25 | GO:0098793 |
| GeneOntologyCellularComponent | dendritic growth cone | 4.83e-04 | 12 | 281 | 3 | GO:0044294 | |
| GeneOntologyCellularComponent | cilium | RSPH14 MYO5A SSX9P SSX6P SSX7 DNAAF11 SSX1 SSX5 DNAH14 CC2D2B CDKL5 RSPH10B2 TBC1D21 WDR49 RSPH10B DNAH10 PCDH11Y NPHP3 CEP89 SSX3 CFAP69 BBS12 ATP2B2 ATP2B4 DNAH11 | 4.96e-04 | 898 | 281 | 25 | GO:0005929 |
| GeneOntologyCellularComponent | spine apparatus membrane | 5.35e-04 | 3 | 281 | 2 | GO:0098897 | |
| GeneOntologyCellularComponent | mitochondrion-derived vesicle | 5.35e-04 | 3 | 281 | 2 | GO:0099073 | |
| GeneOntologyCellularComponent | Cry-Per complex | 5.35e-04 | 3 | 281 | 2 | GO:1990512 | |
| GeneOntologyCellularComponent | microtubule | APC2 ZNF804A DNAH14 STIM1 RASSF5 KIF2B SYNJ1 TRIM55 KIF28P TBCD DNAH10 TRIM54 DNM1L RASSF1 MX1 DCTN3 DNAH11 | 9.43e-04 | 533 | 281 | 17 | GO:0005874 |
| GeneOntologyCellularComponent | dendritic tree | MYO5A ZNF804A CHRNA7 KLHL20 ITPR3 CDKL5 NLGN3 SLITRK2 CYFIP1 KCNAB1 RABGEF1 CHRFAM7A CNN3 CASC3 FAT3 L1CAM DOCK10 RIT2 TANC1 TRAK2 MDGA1 ATP2B1 ATP2B2 | 1.41e-03 | 860 | 281 | 23 | GO:0097447 |
| GeneOntologyCellularComponent | growth cone | MYO5A ZNF804A CHRNA7 STIM1 CDKL5 CYFIP1 CHRFAM7A L1CAM DOCK7 TRAK2 | 1.85e-03 | 245 | 281 | 10 | GO:0030426 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | GAK MYO9B APC2 GBP1 GBP3 KLHL20 ITPR3 CDKL5 FAT1 CYFIP1 PER2 SYNJ1 DOCK6 CASC3 ANK2 DNM1L PPARG CYFIP2 TG ARHGAP1 VPS35 CDH13 MX1 DCTN3 | 1.90e-03 | 934 | 281 | 24 | GO:0048471 |
| GeneOntologyCellularComponent | ruffle | 1.95e-03 | 206 | 281 | 9 | GO:0001726 | |
| GeneOntologyCellularComponent | glycinergic synapse | 2.31e-03 | 20 | 281 | 3 | GO:0098690 | |
| GeneOntologyCellularComponent | filopodium tip | 2.31e-03 | 20 | 281 | 3 | GO:0032433 | |
| GeneOntologyCellularComponent | dendrite terminus | 2.31e-03 | 20 | 281 | 3 | GO:0044292 | |
| GeneOntologyCellularComponent | site of polarized growth | MYO5A ZNF804A CHRNA7 STIM1 CDKL5 CYFIP1 CHRFAM7A L1CAM DOCK7 TRAK2 | 2.33e-03 | 253 | 281 | 10 | GO:0030427 |
| GeneOntologyCellularComponent | adherens junction | 2.37e-03 | 212 | 281 | 9 | GO:0005912 | |
| GeneOntologyCellularComponent | distal axon | MYO5A ZNF804A CHRNA7 STIM1 CDKL5 CYFIP1 SYNJ1 CHRFAM7A MICAL1 L1CAM DOCK7 TANC1 TRAK2 CDH8 | 2.40e-03 | 435 | 281 | 14 | GO:0150034 |
| GeneOntologyCellularComponent | host intracellular region | 2.61e-03 | 6 | 281 | 2 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 2.61e-03 | 6 | 281 | 2 | GO:0030430 | |
| GeneOntologyCellularComponent | host cell part | 2.61e-03 | 6 | 281 | 2 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 2.61e-03 | 6 | 281 | 2 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 2.61e-03 | 6 | 281 | 2 | GO:0033655 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 2.61e-03 | 6 | 281 | 2 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 2.61e-03 | 6 | 281 | 2 | GO:0020005 | |
| GeneOntologyCellularComponent | dendrite | MYO5A ZNF804A CHRNA7 KLHL20 ITPR3 CDKL5 NLGN3 SLITRK2 CYFIP1 KCNAB1 RABGEF1 CHRFAM7A CNN3 CASC3 FAT3 L1CAM DOCK10 TANC1 TRAK2 MDGA1 ATP2B1 ATP2B2 | 2.98e-03 | 858 | 281 | 22 | GO:0030425 |
| Domain | KRAB_RELATED | 4.25e-11 | 11 | 274 | 7 | PS50806 | |
| Domain | Krueppel-associated_box-rel | 2.16e-10 | 13 | 274 | 7 | IPR003655 | |
| Domain | Cadherin_CS | FAT1 PCDHB1 PCDHGB7 PCDHGB5 PCDHGB2 FAT3 PCDH11Y PCDHB10 PCDHB9 PCDHAC1 CDH6 CDH8 CDH12 CDH13 | 7.10e-10 | 109 | 274 | 14 | IPR020894 |
| Domain | CADHERIN_1 | FAT1 PCDHB1 PCDHGB7 PCDHGB5 PCDHGB2 FAT3 PCDH11Y PCDHB10 PCDHB9 PCDHAC1 CDH6 CDH8 CDH12 CDH13 | 1.15e-09 | 113 | 274 | 14 | PS00232 |
| Domain | Cadherin | FAT1 PCDHB1 PCDHGB7 PCDHGB5 PCDHGB2 FAT3 PCDH11Y PCDHB10 PCDHB9 PCDHAC1 CDH6 CDH8 CDH12 CDH13 | 1.15e-09 | 113 | 274 | 14 | PF00028 |
| Domain | - | FAT1 PCDHB1 PCDHGB7 PCDHGB5 PCDHGB2 FAT3 PCDH11Y PCDHB10 PCDHB9 PCDHAC1 CDH6 CDH8 CDH12 CDH13 | 1.30e-09 | 114 | 274 | 14 | 2.60.40.60 |
| Domain | CADHERIN_2 | FAT1 PCDHB1 PCDHGB7 PCDHGB5 PCDHGB2 FAT3 PCDH11Y PCDHB10 PCDHB9 PCDHAC1 CDH6 CDH8 CDH12 CDH13 | 1.30e-09 | 114 | 274 | 14 | PS50268 |
| Domain | CA | FAT1 PCDHB1 PCDHGB7 PCDHGB5 PCDHGB2 FAT3 PCDH11Y PCDHB10 PCDHB9 PCDHAC1 CDH6 CDH8 CDH12 CDH13 | 1.46e-09 | 115 | 274 | 14 | SM00112 |
| Domain | Cadherin-like | FAT1 PCDHB1 PCDHGB7 PCDHGB5 PCDHGB2 FAT3 PCDH11Y PCDHB10 PCDHB9 PCDHAC1 CDH6 CDH8 CDH12 CDH13 | 1.63e-09 | 116 | 274 | 14 | IPR015919 |
| Domain | Cadherin | FAT1 PCDHB1 PCDHGB7 PCDHGB5 PCDHGB2 FAT3 PCDH11Y PCDHB10 PCDHB9 PCDHAC1 CDH6 CDH8 CDH12 CDH13 | 2.05e-09 | 118 | 274 | 14 | IPR002126 |
| Domain | SSX | 3.89e-09 | 6 | 274 | 5 | IPR028804 | |
| Domain | SSXRD | 3.54e-08 | 8 | 274 | 5 | PF09514 | |
| Domain | SSXRD_motif | 3.54e-08 | 8 | 274 | 5 | IPR019041 | |
| Domain | DUF3398 | 6.64e-07 | 6 | 274 | 4 | PF11878 | |
| Domain | DOCK_C/D_N | 6.64e-07 | 6 | 274 | 4 | IPR021816 | |
| Domain | Cadherin_C | 2.36e-06 | 42 | 274 | 7 | IPR032455 | |
| Domain | Cadherin_C_2 | 2.36e-06 | 42 | 274 | 7 | PF16492 | |
| Domain | Phosphorylase | 3.12e-06 | 3 | 274 | 3 | PF00343 | |
| Domain | PHOSPHORYLASE | 3.12e-06 | 3 | 274 | 3 | PS00102 | |
| Domain | Glycg_phsphrylas | 3.12e-06 | 3 | 274 | 3 | IPR011833 | |
| Domain | Glyco_trans_35 | 3.12e-06 | 3 | 274 | 3 | IPR000811 | |
| Domain | Cadherin_2 | PCDHB1 PCDHGB7 PCDHGB5 PCDHGB2 PCDH11Y PCDHB10 PCDHB9 PCDHAC1 | 4.74e-06 | 65 | 274 | 8 | PF08266 |
| Domain | Cadherin_N | PCDHB1 PCDHGB7 PCDHGB5 PCDHGB2 PCDH11Y PCDHB10 PCDHB9 PCDHAC1 | 4.74e-06 | 65 | 274 | 8 | IPR013164 |
| Domain | ATP_Ca_trans_C | 1.24e-05 | 4 | 274 | 3 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 1.24e-05 | 4 | 274 | 3 | PF12424 | |
| Domain | P-type_ATPase_IIB | 1.24e-05 | 4 | 274 | 3 | IPR006408 | |
| Domain | DOCK | 1.38e-05 | 11 | 274 | 4 | IPR026791 | |
| Domain | DOCK_C | 1.38e-05 | 11 | 274 | 4 | IPR010703 | |
| Domain | DOCK-C2 | 1.38e-05 | 11 | 274 | 4 | PF14429 | |
| Domain | DHR-1_domain | 1.38e-05 | 11 | 274 | 4 | IPR027007 | |
| Domain | DHR_2 | 1.38e-05 | 11 | 274 | 4 | PS51651 | |
| Domain | DHR_1 | 1.38e-05 | 11 | 274 | 4 | PS51650 | |
| Domain | DHR-2 | 1.38e-05 | 11 | 274 | 4 | PF06920 | |
| Domain | DHR-2 | 1.38e-05 | 11 | 274 | 4 | IPR027357 | |
| Domain | P-loop_NTPase | MYO5A MYO9B GBP1 GBP3 MCM7 SMC5 DNAH14 LONP1 DDX46 KIF2B HFM1 ASCC3 MOV10 RAD17 DDX49 EP400 DNAH10 MTHFD1L RNF213 DNM1L RIT2 NPHP3 N4BP2 YLPM1 DIRAS2 MX1 DNAH11 | 1.37e-04 | 848 | 274 | 27 | IPR027417 |
| Domain | Cytoplasmic_FMR1-int | 2.14e-04 | 2 | 274 | 2 | IPR008081 | |
| Domain | ATP2B1/4 | 2.14e-04 | 2 | 274 | 2 | IPR030319 | |
| Domain | FragX_IP | 2.14e-04 | 2 | 274 | 2 | PF05994 | |
| Domain | - | GBP1 GBP3 MCM7 SMC5 DNAH14 LONP1 DDX46 HFM1 ASCC3 MOV10 RAD17 DDX49 EP400 DNAH10 MTHFD1L RNF213 DNM1L RIT2 NPHP3 N4BP2 YLPM1 DIRAS2 MX1 DNAH11 | 2.79e-04 | 746 | 274 | 24 | 3.40.50.300 |
| Domain | ARM-type_fold | RSPH14 ARMC3 DOCK11 APC2 URB1 TAF2 TBCD INTS7 UBR4 VPS35 ATM CFAP69 XPOT XPO7 | 5.12e-04 | 339 | 274 | 14 | IPR016024 |
| Domain | Carboxylesterase_B_CS | 8.01e-04 | 13 | 274 | 3 | IPR019819 | |
| Domain | COesterase | 1.01e-03 | 14 | 274 | 3 | PF00135 | |
| Domain | MT | 1.01e-03 | 14 | 274 | 3 | PF12777 | |
| Domain | AAA_8 | 1.01e-03 | 14 | 274 | 3 | PF12780 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.01e-03 | 14 | 274 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.01e-03 | 14 | 274 | 3 | IPR024743 | |
| Domain | CARBOXYLESTERASE_B_2 | 1.01e-03 | 14 | 274 | 3 | PS00941 | |
| Domain | CarbesteraseB | 1.01e-03 | 14 | 274 | 3 | IPR002018 | |
| Domain | DHC_fam | 1.25e-03 | 15 | 274 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.25e-03 | 15 | 274 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.25e-03 | 15 | 274 | 3 | IPR004273 | |
| Domain | Sec63 | 1.26e-03 | 4 | 274 | 2 | PF02889 | |
| Domain | Sec63 | 1.26e-03 | 4 | 274 | 2 | SM00973 | |
| Domain | Sec63-dom | 1.26e-03 | 4 | 274 | 2 | IPR004179 | |
| Domain | DUF1394 | 1.26e-03 | 4 | 274 | 2 | IPR009828 | |
| Domain | DUF1736 | 1.26e-03 | 4 | 274 | 2 | IPR013618 | |
| Domain | RetinoicA-induced_16-like | 1.26e-03 | 4 | 274 | 2 | IPR019384 | |
| Domain | RAI16-like | 1.26e-03 | 4 | 274 | 2 | PF10257 | |
| Domain | Aldehyde_DH_NAD(P) | 1.26e-03 | 4 | 274 | 2 | IPR012394 | |
| Domain | DUF1394 | 1.26e-03 | 4 | 274 | 2 | PF07159 | |
| Domain | DUF1736 | 1.26e-03 | 4 | 274 | 2 | PF08409 | |
| Domain | ATPase_P-typ_TM_dom | 1.52e-03 | 16 | 274 | 3 | IPR023298 | |
| Domain | - | 1.52e-03 | 16 | 274 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cyto_domN | 1.66e-03 | 35 | 274 | 4 | IPR023299 | |
| Domain | Cation_ATPase_C | 1.82e-03 | 17 | 274 | 3 | PF00689 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.82e-03 | 17 | 274 | 3 | IPR006068 | |
| Domain | ATPase_P-typ_P_site | 1.84e-03 | 36 | 274 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 1.84e-03 | 36 | 274 | 4 | IPR001757 | |
| Domain | RA | 1.84e-03 | 36 | 274 | 4 | PF00788 | |
| Domain | ATPASE_E1_E2 | 1.84e-03 | 36 | 274 | 4 | PS00154 | |
| Domain | Cadherin_tail | 2.04e-03 | 37 | 274 | 4 | PF15974 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.04e-03 | 37 | 274 | 4 | IPR008250 | |
| Domain | Cadherin_CBD | 2.04e-03 | 37 | 274 | 4 | IPR031904 | |
| Domain | E1-E2_ATPase | 2.04e-03 | 37 | 274 | 4 | PF00122 | |
| Domain | RA | 2.04e-03 | 37 | 274 | 4 | PS50200 | |
| Domain | HSR | 2.08e-03 | 5 | 274 | 2 | PS51414 | |
| Domain | HSR_dom | 2.08e-03 | 5 | 274 | 2 | IPR004865 | |
| Domain | HSR | 2.08e-03 | 5 | 274 | 2 | PF03172 | |
| Domain | Cation_ATPase_N | 2.16e-03 | 18 | 274 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 2.16e-03 | 18 | 274 | 3 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 2.54e-03 | 19 | 274 | 3 | IPR004014 | |
| Domain | RA_dom | 2.73e-03 | 40 | 274 | 4 | IPR000159 | |
| Domain | Calponin_repeat | 3.09e-03 | 6 | 274 | 2 | IPR000557 | |
| Domain | DDHD | 3.09e-03 | 6 | 274 | 2 | PF02862 | |
| Domain | DDHD | 3.09e-03 | 6 | 274 | 2 | PS51043 | |
| Domain | DDHD_dom | 3.09e-03 | 6 | 274 | 2 | IPR004177 | |
| Domain | Dynamin_M | 3.09e-03 | 6 | 274 | 2 | PF01031 | |
| Domain | Nore1-SARAH | 3.09e-03 | 6 | 274 | 2 | PF16517 | |
| Domain | GED | 3.09e-03 | 6 | 274 | 2 | PS51388 | |
| Domain | CALPONIN_1 | 3.09e-03 | 6 | 274 | 2 | PS01052 | |
| Domain | GED | 3.09e-03 | 6 | 274 | 2 | IPR003130 | |
| Domain | Dynamin_central | 3.09e-03 | 6 | 274 | 2 | IPR000375 | |
| Domain | GED | 3.09e-03 | 6 | 274 | 2 | SM00302 | |
| Domain | Calponin | 3.09e-03 | 6 | 274 | 2 | PF00402 | |
| Domain | C-RASSF | 3.09e-03 | 6 | 274 | 2 | IPR033614 | |
| Domain | GED_dom | 3.09e-03 | 6 | 274 | 2 | IPR020850 | |
| Domain | CALPONIN_2 | 3.09e-03 | 6 | 274 | 2 | PS51122 | |
| Domain | Dynamin_GTPase_CS | 3.09e-03 | 6 | 274 | 2 | IPR019762 | |
| Domain | GED | 3.09e-03 | 6 | 274 | 2 | PF02212 | |
| Domain | DDHD | 3.09e-03 | 6 | 274 | 2 | SM01127 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 3.83e-05 | 28 | 197 | 5 | M924 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | STAM2 DOCK11 MYO9B NDUFA5 ARHGEF11 CYFIP1 KIDINS220 STIP1 ALDH3A2 ARHGAP20 DOCK6 ROCK2 DOCK10 SLITRK3 CYFIP2 ARHGAP1 UBXN11 DOCK7 | 4.46e-05 | 439 | 197 | 18 | MM15595 |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 5.03e-05 | 94 | 197 | 8 | MM15598 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | STAM2 DOCK11 MYO9B NDUFA5 ARHGEF11 CYFIP1 KIDINS220 STIP1 ALDH3A2 ARHGAP20 DOCK6 ROCK2 DOCK10 SLITRK3 CYFIP2 ARHGAP1 UBXN11 DOCK7 | 6.15e-05 | 450 | 197 | 18 | M27078 |
| Pubmed | AKAP8 MYO5A DOCK11 CYTH3 APC2 ARHGEF11 NLGN3 CYFIP1 SYNJ1 FAM120C MORF4L1 KCNAB1 RABGEF1 STIP1 ROCK2 CASC3 IQSEC3 ANK2 UBR4 DNM1L PREPL CYFIP2 FAM171A1 SLC7A3 N4BP2 TAGLN3 YLPM1 DOCK7 DZIP3 SAFB2 ANKRD17 CNOT1 ATP2B4 CUX1 | 7.80e-13 | 963 | 282 | 34 | 28671696 | |
| Pubmed | 3.14e-12 | 21 | 282 | 8 | 12216073 | ||
| Pubmed | 2.22e-11 | 9 | 282 | 6 | 14611804 | ||
| Pubmed | STAM2 GAK AKAP8 MYO5A PSMD8 NDUFA5 DNAJC22 ITPR3 STIM1 URB1 KIDINS220 TMTC3 STIP1 DDHD2 ASCC3 ALDH3A2 MRPL20 ANK2 VEZT MTHFD1L C1orf43 UBR4 PREPL PCF11 FAM171A1 ARHGAP1 NBAS GTF2A1 CEP89 N4BP2 VPS35 TMEM209 TANC1 ATM ATP2B1 ATP2B4 EDRF1 TOP2B CUX1 | 1.19e-10 | 1487 | 282 | 39 | 33957083 | |
| Pubmed | AKAP8 MYO5A VPS45 PDZK1 ARHGEF11 KNOP1 GREB1L URB1 DDX46 CYFIP1 KIDINS220 FAM120C MORF4L1 SUPT7L KDM2B STIP1 TAF2 ASCC3 ALDH3A2 FHIP1A MOV10 CASC3 DDX49 SFSWAP EP400 NOP16 INTS7 MTHFD1L FBXO11 CYFIP2 PCF11 MYOF ZNF800 APPL2 RBM6 ANKRD17 TANC1 SF3A2 EDRF1 | 1.45e-10 | 1497 | 282 | 39 | 31527615 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYO5A VPS45 L2HGDH MGLL ATP8B1 COG3 SSX2 DNAH14 NLGN3 KIDINS220 FAM120C ARHGEF37 ALDH3B2 ZSWIM4 DOCK6 TBCD CASC3 LRRN1 VEZT PCDH11Y SMURF1 LAMA3 RNF213 SLITRK3 ZNF248 ZNF718 TBCK NEMF VPS41 RBM6 ANKRD17 TANC1 CFAP69 ATP2B1 CNOT1 CUX1 XPO7 | 1.63e-09 | 1489 | 282 | 37 | 28611215 |
| Pubmed | 1.86e-09 | 8 | 282 | 5 | 12007189 | ||
| Pubmed | GAK AKAP8 VPS45 L2HGDH MCM7 IRF7 NDUFA5 COG3 ITPR3 LONP1 URB1 DDX46 ALG5 STIP1 ASCC3 ALDH3A2 MOV10 NOP16 MTHFD1L UBR4 CGAS RNF213 NBAS MYOF VPS35 DOCK7 TMEM209 ATM ATP2B1 CNOT1 PCK2 TOP2B CUX1 MX1 XPOT | 8.22e-09 | 1440 | 282 | 35 | 30833792 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SECISBP2L VPS45 MCM7 PSMD8 DNAAF11 NDUFA5 STIM1 LONP1 CYFIP1 AMOTL1 PYGL RABGEF1 POMK RSPH10B MOV10 TBCD ROCK2 FANCL SHOC2 NPHP3 NANS DDHD1 DOCK7 DZIP3 BBS12 FGD6 ATP2B2 CNOT1 HCCS EDRF1 PCK2 DCTN3 | 4.09e-08 | 1321 | 282 | 32 | 27173435 |
| Pubmed | GAK MYO5A VPS45 ARHGEF11 CDKL5 NLGN3 LONP1 CYFIP1 KIDINS220 SYNJ1 FAM120C PYGB STIP1 ROCK2 MICAL1 IQSEC3 ANK2 L1CAM SMURF1 DNM1L CYFIP2 APPL2 VPS35 TAGLN3 DOCK7 TANC1 USP54 ATP2B1 ATP2B2 CNOT1 ATP2B4 DIRAS2 DNAH11 | 7.80e-08 | 1431 | 282 | 33 | 37142655 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | MYO5A MYO9B ITPR3 TMTC3 ASCC3 DOCK6 NBAS MYOF DOCK7 ANKRD17 CNOT1 TOP2B | 1.13e-07 | 202 | 282 | 12 | 33005030 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHB1 PCDHGB7 PCDHGB5 PCDHGB2 PCDH11Y PCDHB10 PCDHB9 PCDHAC1 | 1.60e-07 | 74 | 282 | 8 | 10817752 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | SP100 MCM7 SMC5 STIM1 CYFIP1 TMTC3 SP140L MORF4L1 ALG5 TAF2 ALDH3A2 TBCD C1orf43 L1CAM FBXO11 CYFIP2 GTF2A1 ZNF800 P4HTM VPS35 DOCK7 TMEM209 SAFB2 ATP2B1 CNOT1 SF3A2 TOP2B XPOT XPO7 | 2.04e-07 | 1203 | 282 | 29 | 29180619 |
| Pubmed | PCDHB1 PCDHGB7 PCDHGB5 PCDHGB2 PCDH11Y PCDHB10 PCDHB9 PCDHAC1 | 2.19e-07 | 77 | 282 | 8 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHB1 PCDHGB7 PCDHGB5 PCDHGB2 PCDH11Y PCDHB10 PCDHB9 PCDHAC1 | 2.96e-07 | 80 | 282 | 8 | 10716726 |
| Pubmed | GAK NADK2 L2HGDH FAT1 CYFIP1 KIDINS220 TMTC3 MORF4L1 STIP1 ALDH3A2 PCYOX1 ROCK2 NPR3 MTHFD1L UBR4 L1CAM DNM1L SHOC2 ARHGAP1 MYOF P4HTM LPL TAGLN3 NEMF TNFAIP3 IAH1 CNOT1 HCCS SF3A2 XPOT | 2.98e-07 | 1297 | 282 | 30 | 33545068 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | GAK CNNM2 AKAP8 PSMD8 ITPR3 CYFIP1 KIDINS220 ADSL TMTC3 TXNDC16 PYGL STIP1 ASCC3 ALDH3A2 MMP14 ROCK2 MTHFD1L UBR4 DNM1L PREPL ARHGAP1 VPS35 ANKRD17 ATP2B1 XPOT | 4.76e-07 | 974 | 282 | 25 | 28675297 |
| Pubmed | SSX2-4 expression in early-stage non-small cell lung cancer. | 5.27e-07 | 3 | 282 | 3 | 24645645 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | AKAP8 MYO5A DOCK11 ACOT9 SMC5 STIM1 URB1 FAM120C ECI2 TAF2 ASCC3 CNN3 MOV10 CYFIP2 ARHGAP1 MYOF YLPM1 DOCK7 ANKRD17 CNOT1 TOP2B | 5.94e-07 | 724 | 282 | 21 | 36232890 |
| Pubmed | STAM2 GAK MCM7 DDX46 CYFIP1 SYNJ1 AMOTL1 KDM2B TAF2 ASCC3 CNN3 EP400 TEAD1 TET1 YLPM1 DOCK7 CNOT1 CUX1 | 6.90e-07 | 549 | 282 | 18 | 38280479 | |
| Pubmed | SECISBP2L SLITRK1 NLGN3 TXNDC16 DDHD2 MOV10 PCYOX1 ROCK2 LRRN1 RNF213 CRY2 PCF11 MYOF NPHP3 N4BP2 SAFB2 FGD6 | 7.11e-07 | 493 | 282 | 17 | 15368895 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ACACB DOCK11 L2HGDH SMC5 ARHGEF11 SLITRK1 DDX46 CYFIP1 KIF2B ASCC3 COL6A6 MTHFD1L PCDHB9 VPS35 ATM CNOT1 XPOT | 7.94e-07 | 497 | 282 | 17 | 36774506 |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 8.03e-07 | 91 | 282 | 8 | 28558017 | |
| Pubmed | Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue. | 8.55e-07 | 10 | 282 | 4 | 2059658 | |
| Pubmed | EFCAB5 SP100 ACACB ARMC3 MYO5A PSMD8 NDUFA5 KNOP1 TMPRSS7 ROCK2 ANK2 PCDHGB7 PCDHGB5 PCDHGB2 GRK5 UBR4 MINDY2 CYFIP2 PCF11 N4BP2 VPS35 YLPM1 SAFB2 ATM CFAP69 ATP2B1 ATP2B2 SF3A2 TOP2B CUX1 SLC4A11 | 8.89e-07 | 1442 | 282 | 31 | 35575683 | |
| Pubmed | GAK URB1 KIDINS220 ASCC3 YLPM1 DOCK7 USP54 TRIM40 ATP2B1 ATP2B2 CNOT1 | 9.06e-07 | 202 | 282 | 11 | 24639526 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | AKAP8 PSMD8 NDUFA5 ITPR3 STIM1 URB1 KIDINS220 TMTC3 ALG5 ASCC3 ALDH3A2 POMK TBCD VEZT INTS7 C1orf43 UBR4 VPS35 TMEM209 ANKRD17 ATP2B4 PCK2 XPOT XPO7 | 9.27e-07 | 942 | 282 | 24 | 31073040 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 1.36e-06 | 68 | 282 | 7 | 11230163 | |
| Pubmed | AKAP8 ACACB VPS45 MCM7 KNOP1 STIM1 CDKL5 FAT1 KIDINS220 AMOTL1 SFSWAP EP400 RNF213 DNM1L MAGEC3 PCF11 ARHGAP1 DENND6A DOCK7 CUX1 XPO7 | 1.82e-06 | 777 | 282 | 21 | 35844135 | |
| Pubmed | 1.92e-06 | 102 | 282 | 8 | 11214970 | ||
| Pubmed | MYO5A ITPR3 LONP1 URB1 DDX46 PYGB PYGL ASCC3 MOV10 MTHFD1L UBR4 YLPM1 DOCK7 RBM6 ANKRD17 ATM CNOT1 XPOT XPO7 | 1.98e-06 | 653 | 282 | 19 | 22586326 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 2.01e-06 | 72 | 282 | 7 | 10380929 | |
| Pubmed | Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. | 2.10e-06 | 4 | 282 | 3 | 12209837 | |
| Pubmed | 2.10e-06 | 4 | 282 | 3 | 23413890 | ||
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 2.10e-06 | 4 | 282 | 3 | 8245032 | |
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 2.10e-06 | 4 | 282 | 3 | 7989379 | |
| Pubmed | PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†. | 2.10e-06 | 4 | 282 | 3 | 36130203 | |
| Pubmed | Expressions of cancer-testis antigens in human hepatocellular carcinomas. | 2.10e-06 | 4 | 282 | 3 | 11179834 | |
| Pubmed | 2.10e-06 | 4 | 282 | 3 | 29265373 | ||
| Pubmed | 2.10e-06 | 4 | 282 | 3 | 10577388 | ||
| Pubmed | Structural organization, ion transport, and energy transduction of P-type ATPases. | 2.10e-06 | 4 | 282 | 3 | 8634322 | |
| Pubmed | 2.10e-06 | 4 | 282 | 3 | 12784250 | ||
| Pubmed | The prion protein ligand, stress-inducible phosphoprotein 1, regulates amyloid-β oligomer toxicity. | 2.10e-06 | 4 | 282 | 3 | 24133259 | |
| Pubmed | Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. | 2.10e-06 | 4 | 282 | 3 | 11152753 | |
| Pubmed | Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines. | 2.10e-06 | 4 | 282 | 3 | 10749136 | |
| Pubmed | Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse. | 2.10e-06 | 4 | 282 | 3 | 10434059 | |
| Pubmed | PER2 controls lipid metabolism by direct regulation of PPARγ. | 2.10e-06 | 4 | 282 | 3 | 21035761 | |
| Pubmed | 2.10e-06 | 4 | 282 | 3 | 15101689 | ||
| Pubmed | Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas. | 2.10e-06 | 4 | 282 | 3 | 12037676 | |
| Pubmed | Phosphatidic acid (PA)-preferring phospholipase A1 regulates mitochondrial dynamics. | 2.10e-06 | 4 | 282 | 3 | 24599962 | |
| Pubmed | Molecular mechanisms underlying human synovial sarcoma development. | 2.10e-06 | 4 | 282 | 3 | 11107170 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | STAM2 AKAP8 DOCK11 INPPL1 STIM1 SYNJ1 RABGEF1 DOCK6 CASC3 DNM1L FAM171A1 CEP89 N4BP2 TET1 DOCK7 ANKRD17 TANC1 TNFAIP3 USP54 FGD6 ATP2B1 EDRF1 | 2.55e-06 | 861 | 282 | 22 | 36931259 |
| Pubmed | 2.86e-06 | 13 | 282 | 4 | 9615235 | ||
| Pubmed | Absence of layer-specific cadherin expression profiles in the neocortex of the reeler mutant mouse. | 3.97e-06 | 14 | 282 | 4 | 20847152 | |
| Pubmed | 3.97e-06 | 14 | 282 | 4 | 12432077 | ||
| Pubmed | ACACB DOCK11 RASSF5 LONP1 AMOTL1 RABGEF1 ALDH3A2 DOCK6 TEAD1 CYFIP2 CEP89 RASSF1 DOCK7 USP54 CNOT1 | 4.36e-06 | 446 | 282 | 15 | 24255178 | |
| Pubmed | 5.21e-06 | 5 | 282 | 3 | 7982033 | ||
| Pubmed | SSX: a multigene family with several members transcribed in normal testis and human cancer. | 5.21e-06 | 5 | 282 | 3 | 9378559 | |
| Pubmed | 5.21e-06 | 5 | 282 | 3 | 17938178 | ||
| Pubmed | 5.38e-06 | 15 | 282 | 4 | 33833667 | ||
| Pubmed | ACACB ITPR3 CYFIP1 TMTC3 SUPT7L KDM2B HFM1 TAF2 FHIP2B UBR4 PREPL DDHD1 ANKRD17 ATP2B1 CNOT1 PCK2 CUX1 DNAH11 | 5.63e-06 | 638 | 282 | 18 | 31182584 | |
| Pubmed | MYO5A CYFIP1 SYNJ1 PYGB STIP1 ROCK2 ANK2 DNM1L CYFIP2 TAGLN3 ATP2B1 ATP2B2 ATP2B4 DIRAS2 | 6.32e-06 | 403 | 282 | 14 | 30562941 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYO5A MYO9B MCM7 LONP1 URB1 CYFIP1 ADSL PYGB PYGL TAF2 ASCC3 MMP14 MOV10 DDX49 EP400 MTHFD1L UBR4 CGAS DOCK10 NANS VPS35 SAFB2 ANKRD17 TANC1 ATP2B1 PCK2 TOP2B XPOT | 6.33e-06 | 1353 | 282 | 28 | 29467282 |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 6.91e-06 | 57 | 282 | 6 | 32633719 | |
| Pubmed | 8.77e-06 | 125 | 282 | 8 | 29467281 | ||
| Pubmed | INPPL1 L2HGDH MCM7 LONP1 ADSL PYGB MRI1 INTS7 MTHFD1L UBR4 VPS35 DOCK7 TMEM209 ANKRD17 ATP2B1 CNOT1 | 8.96e-06 | 534 | 282 | 16 | 35032548 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | DOCK11 SMC5 DDX46 SYNJ1 FAM120C ECI2 NOP16 INTS7 GRK5 UBR4 SHOC2 KRIT1 NEMF DZIP3 TOP2B | 9.24e-06 | 475 | 282 | 15 | 31040226 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | AKAP8 ACOT9 SMC5 URB1 DDX46 PER2 PYGM ALDH3A2 MOV10 TBCD DDX49 POGK SHOC2 CRY2 PCF11 NBAS ZNHIT6 RASSF1 YLPM1 ATM CNOT1 SF3A2 TOP2B DCTN3 TGS1 | 9.57e-06 | 1155 | 282 | 25 | 20360068 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ACACB MYO5A MCM7 LONP1 DDX46 ADSL PYGL STIP1 CNN3 TBCD NOP16 MTHFD1L UBR4 DNM1L GTF2A1 VPS35 CNOT1 PCK2 | 9.87e-06 | 665 | 282 | 18 | 30457570 |
| Pubmed | STAM2 ACACB INPPL1 STIM1 CYFIP1 KIDINS220 ROCK2 CYFIP2 FAM171A1 APPL2 CEP89 ATP2B1 ATP2B4 PCK2 | 1.03e-05 | 421 | 282 | 14 | 36976175 | |
| Pubmed | 1.04e-05 | 6 | 282 | 3 | 12763866 | ||
| Pubmed | 1.04e-05 | 6 | 282 | 3 | 14550773 | ||
| Pubmed | Differential expression of Slitrk family members in the mouse nervous system. | 1.04e-05 | 6 | 282 | 3 | 19924824 | |
| Pubmed | Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange. | 1.04e-05 | 6 | 282 | 3 | 12767889 | |
| Pubmed | CRY1/2 Selectively Repress PPARδ and Limit Exercise Capacity. | 1.04e-05 | 6 | 282 | 3 | 28683290 | |
| Pubmed | 1.04e-05 | 6 | 282 | 3 | 14557068 | ||
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | LONP1 DDX46 KIDINS220 TMTC3 PYGB PYGL STIP1 PCYOX1 L1CAM MYOF VPS35 ATP2B1 ATP2B4 PCK2 | 1.06e-05 | 422 | 282 | 14 | 27342126 |
| Pubmed | ARHGEF11 SP140L KCNAB1 PYGB PYGL HFM1 PPARG NANS RASSF1 TNFAIP3 IL1A TOP2B | 1.10e-05 | 313 | 282 | 12 | 20800603 | |
| Pubmed | PSMD8 KLHL20 ITPR3 PYGB DDHD2 TBCD ROCK2 UBR4 PCDHB10 ARHGAP1 VPS35 CDH13 | 1.46e-05 | 322 | 282 | 12 | 26514267 | |
| Pubmed | PSMD8 CDKL5 KIDINS220 SYNJ1 MTHFD1L C1orf43 RASSF1 VPS35 VPS41 TMEM209 RBM6 TANC1 ATP2B4 | 1.51e-05 | 378 | 282 | 13 | 34315543 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | CNNM2 AKAP8 MYO5A ACOT9 PSMD8 STIM1 URB1 ALG5 ASCC3 DOCK6 MOV10 PCYOX1 INTS7 THTPA USP54 ATP2B1 ATP2B4 CUX1 TGS1 | 1.52e-05 | 754 | 282 | 19 | 33060197 |
| Pubmed | INPPL1 STIM1 LONP1 FAT1 ADSL SYNJ1 AMOTL1 PYGL TAF2 TBCD RAD17 UBR4 CGAS DNM1L ZNHIT6 FGD6 PCK2 DNAH11 | 1.58e-05 | 689 | 282 | 18 | 36543142 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | AKAP8 DOCK11 MCM7 ITPR3 ASCC3 MOV10 EP400 PCF11 YLPM1 TMEM209 RBM6 ANKRD17 USP54 TOP2B | 1.69e-05 | 440 | 282 | 14 | 34244565 |
| Pubmed | AKAP8 ACACB MYO5A PSMD8 NDUFA5 LONP1 FAT1 MORF4L1 SUPT7L KDM2B STIP1 TAF2 MOV10 MRPL20 EP400 DNAH10 NOP16 UBR4 TEAD1 PPARG PCF11 YLPM1 RBM6 ANKRD17 USP54 CNOT1 CUX1 XPOT | 1.71e-05 | 1429 | 282 | 28 | 35140242 | |
| Pubmed | Characterization of cadherins expressed by murine thymocytes. | 1.80e-05 | 7 | 282 | 3 | 8620560 | |
| Pubmed | 1.80e-05 | 7 | 282 | 3 | 30687000 | ||
| Pubmed | 1.80e-05 | 7 | 282 | 3 | 23345436 | ||
| Pubmed | 1.80e-05 | 7 | 282 | 3 | 28386779 | ||
| Pubmed | Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. | 1.80e-05 | 7 | 282 | 3 | 20539819 | |
| Pubmed | 1.80e-05 | 7 | 282 | 3 | 15282546 | ||
| Pubmed | ACACB VPS45 COG3 ITPR3 STIM1 KIF2B MORF4L1 ALG5 ASCC3 CNN3 MOV10 NOP16 UBR4 CRX USP54 | 1.81e-05 | 503 | 282 | 15 | 36217030 | |
| Pubmed | Interferon inducible GBPs restrict Burkholderia thailandensis motility induced cell-cell fusion. | 1.85e-05 | 20 | 282 | 4 | 32150572 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | PDZK1 CDKL5 FAT1 SLITRK2 KIDINS220 NRK TAF2 ROCK2 ANK2 C1orf43 SLITRK3 DOCK7 TANC1 FGD6 ATP2B1 ATP2B4 | 1.95e-05 | 569 | 282 | 16 | 30639242 |
| Pubmed | MYO5A DOCK11 ACOT9 INPPL1 MCM7 NDUFA5 ARHGEF11 KNOP1 LONP1 CYFIP1 STIP1 ARHGAP20 DOCK6 NOP16 DOCK10 PREPL ARHGAP1 DOCK7 RBM6 FGD6 SF3A2 | 2.20e-05 | 916 | 282 | 21 | 32203420 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | NDUFA5 KLHL20 LONP1 ADSL AMOTL1 SUPT7L PYGL STIP1 ECI2 ASCC3 ALDH3A2 RAD17 MTHFD1L FBXO11 PREPL VPS35 YLPM1 DOCK7 ANKRD17 TNFAIP3 CNOT1 SF3A2 | 2.81e-05 | 1005 | 282 | 22 | 19615732 |
| Pubmed | Vaginal Exposure to Zika Virus during Pregnancy Leads to Fetal Brain Infection. | 2.87e-05 | 8 | 282 | 3 | 27565347 | |
| Pubmed | Genetic analysis of Down syndrome-associated heart defects in mice. | 2.87e-05 | 8 | 282 | 3 | 21442329 | |
| Pubmed | Nicotinic receptor Alpha7 expression during tooth morphogenesis reveals functional pleiotropy. | 2.87e-05 | 8 | 282 | 3 | 22666322 | |
| Pubmed | 2.87e-05 | 8 | 282 | 3 | 10951186 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | AKAP8 NDUFA5 KNOP1 DDX46 KIDINS220 MORF4L1 DOCK6 MRPL20 DDX49 SFSWAP EP400 SMURF1 FBXO11 PCF11 NEMF YLPM1 DOCK7 SAFB2 RBM6 ATM CNOT1 SF3A2 TOP2B | 2.91e-05 | 1082 | 282 | 23 | 38697112 |
| Interaction | PCDHGB1 interactions | ACOT9 TMTC2 ALG5 PCDHGB5 PCDHGB2 TRIM54 FAM171A1 ATP2B2 ATP2B4 | 1.20e-06 | 77 | 280 | 9 | int:PCDHGB1 |
| Interaction | RHOF interactions | STAM2 MYO5A DOCK11 MYO9B VPS45 STIM1 LONP1 FAT1 CYFIP1 KIDINS220 TMTC3 STIP1 ALDH3A2 MOV10 ROCK2 KRIT1 FAM171A1 ARHGAP1 MYOF CEP89 DOCK7 TMEM209 TANC1 ATP2B1 TOP2B XPOT | 2.78e-06 | 673 | 280 | 26 | int:RHOF |
| Interaction | SSX7 interactions | 1.11e-05 | 11 | 280 | 4 | int:SSX7 | |
| Interaction | FMR1 interactions | AKAP8 APC2 IMPACT CDKL5 CYFIP1 FAM120C MORF4L1 STIP1 MOV10 ROCK2 CASC3 UBR4 CGAS CYFIP2 FAM171A1 N4BP2 DOCK7 SAFB2 ANKRD17 CNOT1 CUX1 | 2.12e-05 | 536 | 280 | 21 | int:FMR1 |
| Interaction | C10orf88 interactions | 2.87e-05 | 113 | 280 | 9 | int:C10orf88 | |
| Interaction | MTMR7 interactions | 2.93e-05 | 64 | 280 | 7 | int:MTMR7 | |
| Interaction | LRRC31 interactions | MYO5A MYO9B ITPR3 TMTC3 ASCC3 DOCK6 NBAS MYOF DOCK7 ANKRD17 CNOT1 TOP2B | 3.14e-05 | 205 | 280 | 12 | int:LRRC31 |
| Interaction | SSX2 interactions | 3.52e-05 | 45 | 280 | 6 | int:SSX2 | |
| Interaction | LAMP1 interactions | STAM2 MYO5A VPS45 NADK2 STIM1 CDKL5 CYFIP1 KIDINS220 ALG5 ALDH3A2 ROCK2 VEZT UBR4 CYFIP2 ARHGAP1 MYOF DENND6A APPL2 VPS35 TMEM209 TNFAIP3 ATP2B1 CUX1 | 3.67e-05 | 644 | 280 | 23 | int:LAMP1 |
| Interaction | ATXN1 interactions | STAM2 SP100 ACACB MYO5A MCM7 ZNF804A CHRNA7 NLGN3 LONP1 DDX46 ADSL PYGL STIP1 CNN3 TBCD NOP16 MTHFD1L UBR4 DNM1L TEAD1 CRX CRY2 GTF2A1 NPHP3 VPS35 DZIP3 USP54 CNOT1 SF3A2 PCK2 DCTN3 | 5.32e-05 | 1039 | 280 | 31 | int:ATXN1 |
| Interaction | RHOD interactions | STAM2 MYO5A VPS45 NDUFA5 ITPR3 STIM1 LONP1 CYFIP1 KIDINS220 TMTC3 ALDH3A2 ROCK2 DNM1L KRIT1 FAM171A1 ARHGAP1 MYOF CEP89 DOCK7 TMEM209 ATP2B1 | 5.45e-05 | 572 | 280 | 21 | int:RHOD |
| Cytoband | 5q31 | 7.62e-06 | 115 | 282 | 7 | 5q31 | |
| Cytoband | 3q26.1 | 2.54e-05 | 28 | 282 | 4 | 3q26.1 | |
| Cytoband | Xp11.23 | 2.80e-05 | 95 | 282 | 6 | Xp11.23 | |
| Cytoband | 2p24 | 4.84e-05 | 12 | 282 | 3 | 2p24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 5.57e-04 | 298 | 282 | 8 | chr5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp11 | 5.94e-04 | 377 | 282 | 9 | chrXp11 | |
| Cytoband | 1p22.2 | 6.70e-04 | 28 | 282 | 3 | 1p22.2 | |
| GeneFamily | Glycogen phosphorylases | 9.54e-07 | 3 | 179 | 3 | 437 | |
| GeneFamily | Clustered protocadherins | 3.20e-06 | 64 | 179 | 7 | 20 | |
| GeneFamily | ATPases Ca2+ transporting | 7.67e-05 | 9 | 179 | 3 | 1209 | |
| GeneFamily | CD molecules|Type II classical cadherins | 2.54e-04 | 13 | 179 | 3 | 1186 | |
| GeneFamily | Dyneins, axonemal | 5.86e-04 | 17 | 179 | 3 | 536 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 1.66e-03 | 24 | 179 | 3 | 485 | |
| GeneFamily | Exportins | 1.98e-03 | 7 | 179 | 2 | 547 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 1.98e-03 | 7 | 179 | 2 | 785 | |
| GeneFamily | PHD finger proteins | 2.01e-03 | 90 | 179 | 5 | 88 | |
| Coexpression | GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP | IRF7 SP140L SUPT7L KEL MOV10 NRBF2 RNF213 RBCK1 LPL TBCK ATM MX1 | 1.53e-06 | 197 | 280 | 12 | M7545 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SECISBP2L SP100 MYO9B MGLL ATP8B1 SMC5 ZNF804A KLHL20 FAT1 KIDINS220 ASCC3 ROCK2 GRK5 TEAD1 SHOC2 KRIT1 PCF11 TGFB2 FAM171A1 NBAS MYOF RBM6 ANKRD17 ATP2B1 ATP2B4 CUX1 | 1.95e-06 | 856 | 280 | 26 | M4500 |
| Coexpression | GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN | 2.21e-05 | 177 | 280 | 10 | M7632 | |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1 | 2.36e-05 | 6 | 280 | 3 | M5931 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | DOCK11 NADK2 MCM7 SLITRK1 GREB1L SERPINI1 NRK KCNAB1 ARHGAP20 MMP14 FHIP2B LRRN1 SFSWAP C1orf43 L1TD1 RNF213 GTF2A1 ZNF800 APPL2 TET1 DZIP3 ANKRD17 ATP2B1 CDH6 XPOT TGS1 | 1.54e-05 | 804 | 272 | 26 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | DOCK11 SMC5 DDX46 ADSL STIP1 ASCC3 ROCK2 TEAD1 CYFIP2 PCF11 GTF2A1 ZNF800 N4BP2 NEMF RBM6 KDM7A ZC3H12C ATM BBS12 CNOT1 | 1.91e-05 | 532 | 272 | 20 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | EFCAB5 MYO5A CYP2F1 TMTC2 MCM7 SMC5 KNOP1 CDKL5 NLGN3 FAT1 SYNJ1 KDM2B STIP1 TAF2 FHIP2B GAREM1 ANK2 LRRN1 ABHD18 FAT3 L1CAM FBXO11 CYFIP2 CRY2 ZNF800 NPHP3 TAGLN3 DOCK7 OXNAD1 ZC3H12C ATM MDGA1 CDH6 TOP2B CUX1 TGS1 | 3.32e-05 | 1370 | 272 | 36 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | CNNM2 ATP8B1 KCNAB1 ROCK2 MTHFD1L FAT3 DOCK10 LAMA3 MYOF CDH6 | 3.75e-07 | 189 | 282 | 10 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 3.93e-07 | 190 | 282 | 10 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.64e-06 | 183 | 282 | 9 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.91e-06 | 192 | 282 | 9 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | proximal-3-Hematologic-Natural_Killer_T|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.43e-06 | 195 | 282 | 9 | 93093545bb23d2619ace029a52cffa1f673a0c2a | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.43e-06 | 195 | 282 | 9 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | proximal-Hematologic-Natural_Killer_T-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.43e-06 | 195 | 282 | 9 | 4d7c2c4d0130c2d46877ff6dd4584525d8f74daf | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 4.43e-06 | 195 | 282 | 9 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | proximal-Hematologic-Natural_Killer_T|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.43e-06 | 195 | 282 | 9 | 3944e4800f5d904d4efa401ce8913ec0e0781211 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | RSPH14 ARMC3 DNAAF11 RSPH10B2 WDR49 RSPH10B DNAH10 UBXN11 DNAH11 | 5.02e-06 | 198 | 282 | 9 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.02e-06 | 198 | 282 | 9 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-06 | 199 | 282 | 9 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 5.44e-06 | 200 | 282 | 9 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.44e-06 | 200 | 282 | 9 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | MGLL SERPINI1 KIDINS220 ARHGAP20 ANK2 FAT3 PCDH11Y LPL ATP2B1 | 5.44e-06 | 200 | 282 | 9 | db10f76938af553d1a2275bb02ef75dff3c3135b |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | MGLL SERPINI1 KIDINS220 ARHGAP20 ANK2 FAT3 PCDH11Y LPL ATP2B1 | 5.44e-06 | 200 | 282 | 9 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 5.44e-06 | 200 | 282 | 9 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.19e-06 | 116 | 282 | 7 | f2bf9599040f43b5ea8724841d7b71c0a859c016 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 165 | 282 | 8 | a74751e0ec857aa974bec04ccc747c004a8f6e01 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.11e-05 | 166 | 282 | 8 | ceb0a48c0d853448fd45ac31dde046df9a178571 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-05 | 169 | 282 | 8 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-05 | 169 | 282 | 8 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-05 | 171 | 282 | 8 | fdd96c6fe850bd10e1e0d0f18c4401f8348b7d2c | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-05 | 173 | 282 | 8 | 12f779b8dce79431b2d1002ba524dd3f9566aeb0 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 125 | 282 | 7 | 35042ed43045dddc341b76cc5f9fe31b5ba0abb8 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.56e-05 | 174 | 282 | 8 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | RSV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 1.62e-05 | 175 | 282 | 8 | ff3a27f512a3a710ebc863b7b75cce8167d5440b | |
| ToppCell | RSV-Healthy-1|RSV / Virus stimulation, Condition and Cluster | 1.62e-05 | 175 | 282 | 8 | ca52b99b03535a5b3a2751d6981708dc5b255b91 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.91e-05 | 179 | 282 | 8 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.91e-05 | 179 | 282 | 8 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.91e-05 | 179 | 282 | 8 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 181 | 282 | 8 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 181 | 282 | 8 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | wk_15-18-Epithelial-PNS-SST+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.15e-05 | 182 | 282 | 8 | a7e77aaaddabf78c7784f72b3431703fc5ee4a8c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.42e-05 | 185 | 282 | 8 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | 18-Distal-Epithelial-Epithelial|Distal / Age, Tissue, Lineage and Cell class | 2.42e-05 | 185 | 282 | 8 | d2a266724f3f70f746a78034f308d98f8b7a66e3 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.42e-05 | 185 | 282 | 8 | a8946379fc066903fe8f4bc9cbf693b7b424a0cd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-05 | 186 | 282 | 8 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 2.51e-05 | 186 | 282 | 8 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.71e-05 | 188 | 282 | 8 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 2.71e-05 | 188 | 282 | 8 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 189 | 282 | 8 | ff637ae0afdb1fdc67451be7e1e4fe575fbcfff4 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.82e-05 | 189 | 282 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 189 | 282 | 8 | e127e3be626bc513e151d41812f0b7adb89d5da6 | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 2.93e-05 | 190 | 282 | 8 | 2592765016f291565697265800a232b2edef3792 | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.04e-05 | 191 | 282 | 8 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.04e-05 | 191 | 282 | 8 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | ASK454-Epithelial-Secretory|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.04e-05 | 191 | 282 | 8 | c63c781e7e93265e591cf494cb4ce8ed797c24fb | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.04e-05 | 191 | 282 | 8 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.04e-05 | 191 | 282 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.04e-05 | 191 | 282 | 8 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 3.04e-05 | 191 | 282 | 8 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.15e-05 | 192 | 282 | 8 | 3fc7a661ef39286abfd82ed8ab580011f01cb8fd | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.15e-05 | 192 | 282 | 8 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-05 | 192 | 282 | 8 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | wk_08-11-Epithelial-PNS-KCNIP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.15e-05 | 192 | 282 | 8 | 53642c88891f4e4e14b1740c5ced759b7d8b3572 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 3.15e-05 | 192 | 282 | 8 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.15e-05 | 192 | 282 | 8 | 5000440dc1ed17e7474d340921bdff945646f27e | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.27e-05 | 193 | 282 | 8 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | wk_15-18-Epithelial-PNS|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.27e-05 | 193 | 282 | 8 | ca65f8f93058ad50d89e69e06c10deeb46dbfc87 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.27e-05 | 193 | 282 | 8 | ba6eb29478d16589172f48f9992e5116328c81d6 | |
| ToppCell | droplet-Lung-LUNG-1m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-05 | 194 | 282 | 8 | 621e0e8fe77ff0be83ea9287ce46e97c47e2b3b9 | |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.39e-05 | 194 | 282 | 8 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 | |
| ToppCell | droplet-Lung-1m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.39e-05 | 194 | 282 | 8 | d16ab5f0cfe73afe6c551fd3123d14784a082f56 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 3.52e-05 | 195 | 282 | 8 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 3.52e-05 | 195 | 282 | 8 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | pdx-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.73e-05 | 144 | 282 | 7 | 0b94d978262a826c9254145aa98c6c30240243f9 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 3.78e-05 | 197 | 282 | 8 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | severe-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.78e-05 | 197 | 282 | 8 | c8a90d82170cf20e14aebecddcf7cc0ca56cda87 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 3.78e-05 | 197 | 282 | 8 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.78e-05 | 197 | 282 | 8 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.78e-05 | 197 | 282 | 8 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.78e-05 | 197 | 282 | 8 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.78e-05 | 197 | 282 | 8 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.92e-05 | 198 | 282 | 8 | 52ddc1f1ed4ac4c3bac794c90b8feb03e3c221c4 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.92e-05 | 198 | 282 | 8 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.07e-05 | 199 | 282 | 8 | fde8e3ba19d19069a4d3b8db55bfe6220cf634d5 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.07e-05 | 199 | 282 | 8 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)----L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.21e-05 | 200 | 282 | 8 | 44f0278cb0e4ffcda4af3719d7f5819a10929b9f | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.21e-05 | 200 | 282 | 8 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 4.21e-05 | 200 | 282 | 8 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)---|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.21e-05 | 200 | 282 | 8 | 23da7790e09575b2ca909ed16806b44223bf1017 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.21e-05 | 200 | 282 | 8 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 4.21e-05 | 200 | 282 | 8 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.21e-05 | 200 | 282 | 8 | 91f3df1c5a661ff703835f58a35cee93f18eb15c | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.21e-05 | 200 | 282 | 8 | 7668ae7ed550583ab59e419c5c9bb9f2d7e8e0d5 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.21e-05 | 200 | 282 | 8 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.21e-05 | 200 | 282 | 8 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.21e-05 | 200 | 282 | 8 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.21e-05 | 200 | 282 | 8 | 2e2b1d252972b702ade25526ec8461bf613d81b0 | |
| ToppCell | FLU-Healthy-1|FLU / Virus stimulation, Condition and Cluster | 6.99e-05 | 159 | 282 | 7 | fe2a9f79b058e89214256e736f6e266830cdfa28 | |
| ToppCell | FLU-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 6.99e-05 | 159 | 282 | 7 | 97c8e16a7ac10ebba96daee97f9fb1d4a404f23b | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.27e-05 | 160 | 282 | 7 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-05 | 163 | 282 | 7 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-05 | 165 | 282 | 7 | 1703d3eb644b3c743ad3c5532b1d29ea010c79c8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.16e-05 | 166 | 282 | 7 | 8e2faca6a2e76a625de04d6098aa6f98911945c6 | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 168 | 282 | 7 | 2201ae834b53cbdc085f8f02607fa5b5bd911268 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.02e-04 | 169 | 282 | 7 | d9c3b22f62b882b8a2ea6fd9cf7afbe6d1775745 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-04 | 169 | 282 | 7 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-04 | 169 | 282 | 7 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| Drug | Loxapine succinate [27833-64-3]; Down 200; 9uM; MCF7; HT_HG-U133A | SP100 AKAP8 MYO9B DOCK6 DDX49 ABHD18 INTS7 LAMA3 FBXO11 CYFIP2 DZIP3 SAFB2 ATM CUX1 | 1.56e-07 | 196 | 280 | 14 | 5293_DN |
| Drug | Gvapspat amide | 7.37e-07 | 15 | 280 | 5 | CID000125015 | |
| Drug | hydantocidin | 7.61e-07 | 7 | 280 | 4 | CID000125429 | |
| Drug | Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; HL60; HT_HG-U133A | STAM2 SSX1 SYNJ1 ALDH3A2 GAREM1 ANK2 TEX15 YLPM1 SAFB2 CFAP69 ATP2B2 CDH6 CUX1 | 1.20e-06 | 199 | 280 | 13 | 3017_DN |
| Drug | 3,5-dimethylphenyl isocyanate | 1.84e-06 | 3 | 280 | 3 | CID000521488 | |
| Drug | 5'-deoxy-5'-fluoro-5'-(methylthio)adenosine | 1.84e-06 | 3 | 280 | 3 | CID000147839 | |
| Drug | NSC758405 | 1.84e-06 | 3 | 280 | 3 | CID000003201 | |
| Drug | 3,5-dinitrophenyl phosphate | 1.84e-06 | 3 | 280 | 3 | CID000151920 | |
| Drug | pyridoxal phosphoglucose | 1.84e-06 | 3 | 280 | 3 | CID000196007 | |
| Drug | 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone | 1.84e-06 | 3 | 280 | 3 | CID000093111 | |
| Drug | adenosine-5'-chloromethylphosphonate | 1.84e-06 | 3 | 280 | 3 | CID000191554 | |
| Drug | hydan | 1.84e-06 | 3 | 280 | 3 | CID000008360 | |
| Drug | EHMF | 1.84e-06 | 3 | 280 | 3 | CID000033931 | |
| Drug | pyridoxal 5'-methylenephosphonate | 1.84e-06 | 3 | 280 | 3 | CID003082249 | |
| Drug | Plp 5'-mpa | 1.84e-06 | 3 | 280 | 3 | CID003082151 | |
| Drug | glucose-1,2-cyclic phosphate | 1.84e-06 | 3 | 280 | 3 | CID000191723 | |
| Drug | 3'-FFdUrd | 1.84e-06 | 3 | 280 | 3 | CID000072260 | |
| Drug | 2',3',4',5,5'-pentachloro-2-biphenylol | 1.84e-06 | 3 | 280 | 3 | CID000119518 | |
| Drug | AC1L8XK3 | 1.84e-06 | 3 | 280 | 3 | CID000409735 | |
| Drug | N-acetyl-N'-beta-D-glucopyranosyl urea | 1.84e-06 | 3 | 280 | 3 | CID000446801 | |
| Drug | riboflavin tetraacetate | 1.84e-06 | 3 | 280 | 3 | CID000094186 | |
| Drug | 2,5-dimethyl-3-furanone | 1.84e-06 | 3 | 280 | 3 | CID000085730 | |
| Drug | 3,5-dinitrophenol | 1.84e-06 | 3 | 280 | 3 | CID000011459 | |
| Drug | mag-fura-2 | 5.53e-06 | 37 | 280 | 6 | CID000123839 | |
| Drug | Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A | SERPINI1 DOCK6 VEZT GRK5 MAGEC3 FBXO11 KRIT1 TGFB2 GTF2A1 ATM TNFAIP3 CFAP69 | 6.05e-06 | 196 | 280 | 12 | 4720_UP |
| Drug | galocitabine | 7.29e-06 | 4 | 280 | 3 | CID000065950 | |
| Drug | 2-iodo-7,8-dibromodibenzo-p-dioxin | 7.29e-06 | 4 | 280 | 3 | CID000159485 | |
| Drug | 5-deoxyribose-1-phosphate | 7.29e-06 | 4 | 280 | 3 | CID000135786 | |
| Drug | ingliforib | 7.29e-06 | 4 | 280 | 3 | CID006451325 | |
| Drug | uric acid riboside | 7.29e-06 | 4 | 280 | 3 | CID000164933 | |
| Drug | pseudo-dl-glucose | 7.29e-06 | 4 | 280 | 3 | CID000125259 | |
| Drug | pyridoxal diphosphate | 7.29e-06 | 4 | 280 | 3 | CID000125696 | |
| Drug | 2,5-anhydro-D-mannitol 1-phosphate | 7.29e-06 | 4 | 280 | 3 | CID000189134 | |
| Drug | AC1LAMW2 | 7.29e-06 | 4 | 280 | 3 | CID000491364 | |
| Drug | FdUrd-C8 | 7.29e-06 | 4 | 280 | 3 | CID000094262 | |
| Drug | Mem-CC | 7.29e-06 | 4 | 280 | 3 | CID003081269 | |
| Drug | BCIp4A | 7.29e-06 | 4 | 280 | 3 | CID000192417 | |
| Drug | 3'-chloromethotrexate | 7.29e-06 | 4 | 280 | 3 | CID000097703 | |
| Drug | heptulose-2-P | 1.81e-05 | 5 | 280 | 3 | CID000124823 | |
| Drug | 6-FPLP | 1.81e-05 | 5 | 280 | 3 | CID000146246 | |
| Drug | gluconohydroximo-1,5-lactone | 1.81e-05 | 5 | 280 | 3 | CID009576855 | |
| Drug | DHPBU | 1.81e-05 | 5 | 280 | 3 | CID000125914 | |
| Drug | 5'-isobutylthioinosine | 1.81e-05 | 5 | 280 | 3 | CID003080910 | |
| Drug | indirubin-5-sulphonate | 1.81e-05 | 5 | 280 | 3 | CID005288641 | |
| Drug | AC1LCUXJ | 1.81e-05 | 5 | 280 | 3 | CID000656425 | |
| Drug | 6-amino-5-bromouracil | 1.81e-05 | 5 | 280 | 3 | CID000080578 | |
| Drug | etafenone | 1.81e-05 | 5 | 280 | 3 | CID000003275 | |
| Drug | ddEtUrd | 1.81e-05 | 5 | 280 | 3 | CID000451452 | |
| Drug | 5-trifluoromethyl-2'-deoxycytidine | 1.81e-05 | 5 | 280 | 3 | CID000125618 | |
| Drug | m-anisidine | 1.81e-05 | 5 | 280 | 3 | CID000010824 | |
| Drug | 2-hydroxypropylphosphonate | 1.81e-05 | 5 | 280 | 3 | CID000441028 | |
| Drug | 6-FDPL | 1.81e-05 | 5 | 280 | 3 | CID000129578 | |
| Drug | 3'-O-methylpyridoxal 5'-phosphate | 1.81e-05 | 5 | 280 | 3 | CID003082179 | |
| Drug | GlcMan | 1.81e-05 | 5 | 280 | 3 | CID000152120 | |
| Drug | U66985 | 1.81e-05 | 5 | 280 | 3 | CID000127224 | |
| Drug | AC1O3M08 | 1.81e-05 | 5 | 280 | 3 | CID006331955 | |
| Drug | sotolon | 2.75e-05 | 15 | 280 | 4 | CID000062835 | |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; PC3; HT_HG-U133A | STAM2 URB1 SUPT7L MMP14 TBCD ABHD18 FBXO11 GTF2A1 TAGLN3 VPS41 CFAP69 | 3.16e-05 | 195 | 280 | 11 | 4220_DN |
| Drug | Methiazole; Down 200; 15uM; PC3; HT_HG-U133A | SP100 CYTH3 GBP1 KLHL20 GREB1L PER2 FAM120C VEZT KDM8 CDH6 EDRF1 | 3.32e-05 | 196 | 280 | 11 | 3796_DN |
| Drug | Thimerosal | SECISBP2L ACACB MYO5A NIPSNAP3B DOCK11 CA14 NDUFA5 COG3 CC2D2B ITPR3 TMTC3 PYGL ALDH3A2 DOCK6 WDR49 GAREM1 ANK2 EP400 TEAD1 SHOC2 PREPL NBAS GTF2A1 SLC7A3 APPL2 CEP89 TET1 ZC3H12C ATM FGD6 CDH8 SF3A2 | 3.32e-05 | 1199 | 280 | 32 | ctd:D013849 |
| Drug | Equilin [474-86-2]; Down 200; 15uM; HL60; HT_HG-U133A | IRF7 ARHGEF11 SYNJ1 DOCK6 ROCK2 MYOF VPS41 TMEM209 KDM8 CFAP69 CDH6 | 3.47e-05 | 197 | 280 | 11 | 3039_DN |
| Drug | Primidone [125-33-7]; Down 200; 18.4uM; HL60; HT_HG-U133A | DNAAF11 ITPR3 ALDH3B2 ANK2 SMURF1 CYFIP2 TAGLN3 YLPM1 ATP2B2 CDH6 CDH8 | 3.47e-05 | 197 | 280 | 11 | 3065_DN |
| Drug | Tranexamic acid [1197-18-8]; Up 200; 25.4uM; MCF7; HT_HG-U133A | NIPSNAP3B MYO9B APC2 ITPR3 GREB1L SYNJ1 FAM120C KCNAB1 TG TAGLN3 TMEM209 | 3.47e-05 | 197 | 280 | 11 | 2248_UP |
| Drug | CV-araU | 3.58e-05 | 6 | 280 | 3 | CID006441877 | |
| Drug | 2-thiothymidine | 3.58e-05 | 6 | 280 | 3 | CID003005944 | |
| Drug | Carbocyclic Bvdc | 3.58e-05 | 6 | 280 | 3 | CID006438602 | |
| Drug | 2,2-dimethyl-3-hydroxybutyric acid | 3.58e-05 | 6 | 280 | 3 | CID000152984 | |
| Drug | EdUMP | 3.58e-05 | 6 | 280 | 3 | CID003085112 | |
| Drug | 5'-deoxy-5'-chloroformycin | 3.58e-05 | 6 | 280 | 3 | CID000126430 | |
| Drug | 5-n-propylthioadenosine | 3.58e-05 | 6 | 280 | 3 | CID000656428 | |
| Drug | AzddCyd | 3.58e-05 | 6 | 280 | 3 | CID000451374 | |
| Drug | 5-Ffdru | 3.58e-05 | 6 | 280 | 3 | CID000065561 | |
| Drug | Carbocyclic Ivdu | 3.58e-05 | 6 | 280 | 3 | CID006439191 | |
| Drug | DNPP | 3.58e-05 | 6 | 280 | 3 | CID000067056 | |
| Drug | 5-chloro-indole-2-carboxylic acid | 3.58e-05 | 6 | 280 | 3 | CID000082693 | |
| Drug | NSC-97433 | 3.58e-05 | 6 | 280 | 3 | CID000001803 | |
| Drug | AR-L57 | 3.58e-05 | 6 | 280 | 3 | CID000156890 | |
| Drug | 5-methylthioribose-1-phosphate | 3.63e-05 | 16 | 280 | 4 | CID000000465 | |
| Drug | Thiamphenicol [15318-45-3]; Down 200; 11.2uM; PC3; HT_HG-U133A | SUPT7L STIP1 FHIP2B ROCK2 VEZT SMURF1 RBCK1 TAGLN3 PCIF1 SAFB2 SF3A2 | 3.64e-05 | 198 | 280 | 11 | 1826_DN |
| Drug | Sulindac [38194-50-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | STAM2 CNNM2 ARHGEF11 URB1 FAM120C MMP14 FBXO11 MINDY2 DZIP3 KDM8 CDH6 | 3.81e-05 | 199 | 280 | 11 | 5103_UP |
| Drug | alpha-(fluoromethyl)dehydroornithine | 6.21e-05 | 7 | 280 | 3 | CID006439607 | |
| Drug | 6-fluoropyridoxal | 6.21e-05 | 7 | 280 | 3 | CID003080803 | |
| Drug | AC1L3372 | 6.21e-05 | 7 | 280 | 3 | CID000108025 | |
| Drug | 1 Gpt | 6.21e-05 | 7 | 280 | 3 | CID000101247 | |
| Drug | formycins | 6.21e-05 | 7 | 280 | 3 | CID000512867 | |
| Drug | 5'-methylthioinosine | 6.21e-05 | 7 | 280 | 3 | CID000161214 | |
| Drug | 2',3'-dideoxy-3'-fluorocytidine | 6.21e-05 | 7 | 280 | 3 | CID000356019 | |
| Drug | heptenitol | 6.21e-05 | 7 | 280 | 3 | CID000188267 | |
| Drug | Promonta | 6.21e-05 | 7 | 280 | 3 | CID000108494 | |
| Drug | ADP alpha S | 7.50e-05 | 19 | 280 | 4 | CID000171069 | |
| Drug | RS-17053 | 7.50e-05 | 19 | 280 | 4 | CID003894573 | |
| Drug | DB01888 | 7.50e-05 | 19 | 280 | 4 | CID005287990 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | CYTH3 INPPL1 ADGRL4 ITPR3 STIM1 NRK SUPT7L PYGB PYGL PYGM ANK2 PPARG KRIT1 UBXN11 LPL ATP2B1 ATP2B2 ATP2B4 XPOT | 8.63e-05 | 568 | 280 | 19 | CID000000806 |
| Drug | 6-methylpurine | 9.84e-05 | 8 | 280 | 3 | CID005287547 | |
| Drug | Etafenone [inn] | 9.84e-05 | 8 | 280 | 3 | CID000066659 | |
| Drug | AC1NUVX5 | 9.84e-05 | 8 | 280 | 3 | CID005461894 | |
| Drug | amorphin | 9.84e-05 | 8 | 280 | 3 | CID000122792 | |
| Drug | orthovanadate | ATP8B1 ALG5 SUPT7L PYGB PYGL PPARG NPHP3 LPL VPS41 IL1A ATP2B1 ATP2B2 ATP2B4 PCK2 TOP2B DNAH11 | 1.07e-04 | 435 | 280 | 16 | CID000061672 |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | SERPINI1 GAREM1 ABHD18 UBR4 TEX15 TEAD1 MCTP1 DZIP3 ATM EDRF1 | 1.08e-04 | 186 | 280 | 10 | 4460_UP |
| Drug | Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; PC3; HT_HG-U133A | KLHL20 KIDINS220 GRK5 FBXO11 TGFB2 RASSF1 YLPM1 TMEM209 ATM ATP2B1 | 1.34e-04 | 191 | 280 | 10 | 4273_DN |
| Disease | mean platelet volume | MYO5A DOCK11 MYO9B ADGRL4 STIM1 RASSF5 KIF28P STIP1 ALDH3A2 WDR49 TBCD MICAL1 PCDHGB7 COL6A6 PCDHGB5 PCDHGB2 GRK5 SMURF1 DOCK10 DNM1L DDHD1 LPL DOCK7 TRIM40 CUX1 TGS1 | 3.25e-06 | 1020 | 272 | 26 | EFO_0004584 |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.51e-05 | 86 | 272 | 7 | EFO_0008595, EFO_0020945 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 1.52e-05 | 6 | 272 | 3 | DOID:0050429 (implicated_via_orthology) | |
| Disease | platelet component distribution width | ARMC3 MYO9B STIM1 CYFIP1 PYGB APOA5 POGK GRK5 DOCK10 DNM1L PPARG DDHD1 LPL DOCK7 RBM6 FGD6 CUX1 TGS1 XPO7 | 8.43e-05 | 755 | 272 | 19 | EFO_0007984 |
| Disease | triglycerides in medium VLDL measurement | 1.53e-04 | 55 | 272 | 5 | EFO_0022155 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.85e-04 | 215 | 272 | 9 | EFO_0008317, EFO_0008591 | |
| Disease | urate measurement, bone density | GBP3 MGLL DNAH14 KIDINS220 MTHFD1L PREPL RBCK1 TG FEZF1 RBM6 ATP2B2 ATP2B4 CDH12 CDH13 SLC4A11 DNAH11 | 2.27e-04 | 619 | 272 | 16 | EFO_0003923, EFO_0004531 |
| Disease | hereditary spastic paraplegia 28 (implicated_via_orthology) | 2.52e-04 | 3 | 272 | 2 | DOID:0110779 (implicated_via_orthology) | |
| Disease | chromosome 15q11.2 deletion syndrome (implicated_via_orthology) | 2.52e-04 | 3 | 272 | 2 | DOID:0060393 (implicated_via_orthology) | |
| Disease | hereditary spastic paraplegia 54 (implicated_via_orthology) | 2.52e-04 | 3 | 272 | 2 | DOID:0110806 (implicated_via_orthology) | |
| Disease | free cholesterol in small HDL measurement | 2.95e-04 | 35 | 272 | 4 | EFO_0022270 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.18e-04 | 139 | 272 | 7 | DOID:3908 (is_implicated_in) | |
| Disease | total lipids in small VLDL | 3.89e-04 | 67 | 272 | 5 | EFO_0022148 | |
| Disease | free cholesterol in large VLDL measurement | 4.16e-04 | 68 | 272 | 5 | EFO_0022265 | |
| Disease | triglyceride measurement, phospholipid measurement | 4.27e-04 | 146 | 272 | 7 | EFO_0004530, EFO_0004639 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 4.59e-04 | 106 | 272 | 6 | EFO_0008317, EFO_0008596 | |
| Disease | Sotos' syndrome | 5.02e-04 | 4 | 272 | 2 | C0175695 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 5.58e-04 | 110 | 272 | 6 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 5.58e-04 | 110 | 272 | 6 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 5.65e-04 | 153 | 272 | 7 | EFO_0004611, EFO_0020944 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 6.00e-04 | 42 | 272 | 4 | EFO_0022255 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 6.15e-04 | 74 | 272 | 5 | DOID:3748 (is_marker_for) | |
| Disease | very low density lipoprotein cholesterol measurement | 7.36e-04 | 260 | 272 | 9 | EFO_0008317 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 9.15e-04 | 166 | 272 | 7 | EFO_0004530, EFO_0004611 | |
| Disease | hypertension (is_implicated_in) | 9.21e-04 | 121 | 272 | 6 | DOID:10763 (is_implicated_in) | |
| Disease | Intellectual Disability | PIGP ACOT9 APC2 L2HGDH ADSL TAF2 ASCC3 ALDH3A2 TBCD IQSEC3 PREPL P4HTM | 9.86e-04 | 447 | 272 | 12 | C3714756 |
| Disease | Seizures | 9.91e-04 | 218 | 272 | 8 | C0036572 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 1.05e-03 | 220 | 272 | 8 | EFO_0004529, EFO_0008317 | |
| Disease | Autism Spectrum Disorders | 1.15e-03 | 85 | 272 | 5 | C1510586 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.18e-03 | 224 | 272 | 8 | EFO_0004530, EFO_0008317 | |
| Disease | cognitive disorder (implicated_via_orthology) | 1.24e-03 | 6 | 272 | 2 | DOID:1561 (implicated_via_orthology) | |
| Disease | Sjogren-Larsson syndrome (implicated_via_orthology) | 1.24e-03 | 6 | 272 | 2 | DOID:14501 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (biomarker_via_orthology) | 1.24e-03 | 6 | 272 | 2 | DOID:7148 (biomarker_via_orthology) | |
| Disease | diacylglycerol 36:1 measurement | 1.24e-03 | 6 | 272 | 2 | EFO_0010354 | |
| Disease | synovial sarcoma | 1.24e-03 | 6 | 272 | 2 | C0039101 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.36e-03 | 229 | 272 | 8 | EFO_0004639, EFO_0008317 | |
| Disease | Dyslipidemias | 1.36e-03 | 24 | 272 | 3 | C0242339 | |
| Disease | Dyslipoproteinemias | 1.36e-03 | 24 | 272 | 3 | C0598784 | |
| Disease | triglycerides in HDL measurement | 1.45e-03 | 53 | 272 | 4 | EFO_0022317 | |
| Disease | Acute kidney injury | 1.53e-03 | 25 | 272 | 3 | HP_0001919 | |
| Disease | triglycerides in medium HDL measurement | 1.56e-03 | 54 | 272 | 4 | EFO_0022321 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.61e-03 | 291 | 272 | 9 | EFO_0008317, EFO_0020946 | |
| Disease | Urogenital Abnormalities | 1.72e-03 | 7 | 272 | 2 | C0042063 | |
| Disease | Abnormality of the eye | 1.72e-03 | 7 | 272 | 2 | C4316870 | |
| Disease | diacylglycerol 34:0 measurement | 1.72e-03 | 7 | 272 | 2 | EFO_0020058 | |
| Disease | triglycerides in large VLDL measurement | 1.78e-03 | 56 | 272 | 4 | EFO_0022178 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 1.90e-03 | 57 | 272 | 4 | EFO_0022284 | |
| Disease | cholesterol to total lipids in small LDL percentage | 1.92e-03 | 27 | 272 | 3 | EFO_0022241 | |
| Disease | cholesterol to total lipids in medium LDL percentage | 1.92e-03 | 27 | 272 | 3 | EFO_0022238 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.93e-03 | 189 | 272 | 7 | EFO_0009932 | |
| Disease | Adenocarcinoma of large intestine | 1.98e-03 | 96 | 272 | 5 | C1319315 | |
| Disease | stomach cancer (is_marker_for) | 2.09e-03 | 142 | 272 | 6 | DOID:10534 (is_marker_for) | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.12e-03 | 303 | 272 | 9 | EFO_0004612, EFO_0020945 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 2.14e-03 | 28 | 272 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | Hyperlipoproteinemia | 2.29e-03 | 8 | 272 | 2 | cv:C0020476 | |
| Disease | Adenoid Cystic Carcinoma | 2.37e-03 | 100 | 272 | 5 | C0010606 | |
| Disease | triglycerides in small VLDL measurement | 2.44e-03 | 61 | 272 | 4 | EFO_0022145 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 2.44e-03 | 61 | 272 | 4 | DOID:3587 (is_marker_for) | |
| Disease | free cholesterol in very large VLDL measurement | 2.44e-03 | 61 | 272 | 4 | EFO_0022274 | |
| Disease | fatty acid measurement | ANKRD31 ACACB GREB1L DOCK6 CNN3 NRBF2 SFSWAP APOA5 LPL PCIF1 DOCK7 | 2.57e-03 | 436 | 272 | 11 | EFO_0005110 |
| Disease | phospholipids in large VLDL measurement | 2.59e-03 | 62 | 272 | 4 | EFO_0022169 | |
| Disease | total lipids in very large VLDL measurement | 2.59e-03 | 62 | 272 | 4 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 2.59e-03 | 62 | 272 | 4 | EFO_0022299 | |
| Disease | caudate nucleus volume | 2.62e-03 | 30 | 272 | 3 | EFO_0004830 | |
| Disease | non-high density lipoprotein cholesterol measurement | ATP8B1 PYGB HFM1 ASCC3 DNAH10 APOA5 PPARG RBCK1 APPL2 RASSF1 LPL PCIF1 DOCK7 TRAK2 DNAH11 | 2.74e-03 | 713 | 272 | 15 | EFO_0005689 |
| Disease | triglycerides to total lipids in medium VLDL percentage | 2.75e-03 | 63 | 272 | 4 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 2.75e-03 | 63 | 272 | 4 | EFO_0022239 | |
| Disease | cholesteryl ester measurement | 2.78e-03 | 257 | 272 | 8 | EFO_0010351 | |
| Disease | cholesterol to total lipids in very large HDL percentage | 2.88e-03 | 31 | 272 | 3 | EFO_0022243 | |
| Disease | insomnia measurement | CNNM2 ITPR3 PER2 ASCC3 TEX15 RBM6 MDGA1 ATP2B2 ATP2B4 CDH8 DNAH11 | 2.90e-03 | 443 | 272 | 11 | EFO_0007876 |
| Disease | fish consumption measurement | 2.91e-03 | 64 | 272 | 4 | EFO_0010139 | |
| Disease | diacylglycerol 36:4 measurement | 2.92e-03 | 9 | 272 | 2 | EFO_0020063 | |
| Disease | triglyceride measurement, blood pressure | 2.92e-03 | 9 | 272 | 2 | EFO_0004325, EFO_0004530 | |
| Disease | glycogen storage disease (is_implicated_in) | 2.92e-03 | 9 | 272 | 2 | DOID:2747 (is_implicated_in) | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.03e-03 | 153 | 272 | 6 | EFO_0004611, EFO_0020946 | |
| Disease | triglycerides in small LDL measurement | 3.08e-03 | 65 | 272 | 4 | EFO_0022323 | |
| Disease | cholesterol in large VLDL measurement | 3.08e-03 | 65 | 272 | 4 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 3.08e-03 | 65 | 272 | 4 | EFO_0022230 | |
| Disease | total lipids in large VLDL | 3.43e-03 | 67 | 272 | 4 | EFO_0022175 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 3.58e-03 | 110 | 272 | 5 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | triglycerides in very small VLDL measurement | 3.62e-03 | 68 | 272 | 4 | EFO_0022144 | |
| Disease | schizophrenia (implicated_via_orthology) | 3.62e-03 | 68 | 272 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | triglycerides to phosphoglycerides ratio | 3.62e-03 | 68 | 272 | 4 | EFO_0022327 | |
| Disease | Optic Atrophy | 3.63e-03 | 10 | 272 | 2 | C0029124 | |
| Disease | diacylglycerol 32.2 measurement | 3.63e-03 | 10 | 272 | 2 | EFO_0020055 | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [2] measurement | 3.63e-03 | 10 | 272 | 2 | EFO_0800333 | |
| Disease | apolipoprotein B measurement | ANKRD31 ACACB PYGB DOCK6 DNAH10 APOA5 TRIM54 PPARG MYOF NPHP3 LPL PCIF1 DOCK7 DNAH11 | 3.63e-03 | 663 | 272 | 14 | EFO_0004615 |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 3.72e-03 | 111 | 272 | 5 | EFO_0004530, EFO_0008595 | |
| Disease | unipolar depression, systolic blood pressure | 3.75e-03 | 34 | 272 | 3 | EFO_0003761, EFO_0006335 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 3.75e-03 | 34 | 272 | 3 | EFO_0009926 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 3.82e-03 | 69 | 272 | 4 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 3.82e-03 | 69 | 272 | 4 | EFO_0022341 | |
| Disease | reticulocyte count | CNNM2 MYO9B GREB1L RASSF5 FAT1 KEL TAF2 NRBF2 DNAH10 LAMA3 PPARG ZNF800 RASSF1 LPL DZIP3 TRIM40 ATP2B1 ATP2B4 CUX1 | 4.02e-03 | 1045 | 272 | 19 | EFO_0007986 |
| Disease | coronary aneurysm | 4.08e-03 | 35 | 272 | 3 | EFO_1000881 | |
| Disease | total lipids in small HDL measurement | 4.08e-03 | 35 | 272 | 3 | EFO_0022311 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.27e-03 | 276 | 272 | 8 | EFO_0004612, EFO_0020943 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 4.41e-03 | 11 | 272 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 4.41e-03 | 11 | 272 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | diacylglycerol 34:3 measurement | 4.41e-03 | 11 | 272 | 2 | EFO_0020059 | |
| Disease | Pancreatic Ductal Adenocarcinoma | 4.41e-03 | 11 | 272 | 2 | C1335302 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IKEPVALLQEVYRNS | 136 | Q9HBW9 | |
| ELVLAYAAPVLDKRQ | 41 | Q96EY9 | |
| LARAPYLLESQEEEK | 246 | P0C875 | |
| RQKALYEDVILQPGT | 1331 | Q96L91 | |
| LPELKTRINVLAAQY | 301 | O00429 | |
| PDKTVEFLQEYIVNR | 426 | O43823 | |
| VNARNVALEAYLIKP | 536 | Q96PE1 | |
| DQALLLVDTYRKEPE | 126 | A1IGU5 | |
| QLSVVVPSYNEEKRL | 66 | Q9Y673 | |
| LIIVVQAKEDAYIPR | 366 | Q0P651 | |
| LRQEEKELQDILPLY | 186 | O15085 | |
| ESTRLFEVALPEYKQ | 1301 | Q96DT5 | |
| SEPELREKYLTVQNT | 96 | Q9Y305 | |
| ENIKESPDYERIINL | 271 | P51648 | |
| YNAPALLELVREKEE | 661 | Q8IY63 | |
| LQEELEEVKARLQPY | 96 | Q6Q788 | |
| PITNIKEQIEDLAKY | 736 | Q5W041 | |
| KDYQFTILDVRPALD | 236 | P53701 | |
| EKVLAEVLPQYLDQS | 66 | P48448 | |
| YARLQQVDPVLLKDE | 926 | O75179 | |
| TLENPKYELIIEAQD | 321 | P55290 | |
| DISNKLEQIPRVYDV | 651 | Q6ZW61 | |
| PLKKEYTEENIQLVA | 761 | Q6UB35 | |
| QDIPKYFRLEQLQDE | 701 | Q6DHV5 | |
| KLEVPRIQLEEYSNT | 231 | Q8N884 | |
| QDVRNEIPEEALYKV | 561 | P20020 | |
| FVLDLKQDYEPVRSQ | 576 | Q01814 | |
| QAVRNEVPEEKLYKV | 551 | P23634 | |
| KYDEPSRQVILEALA | 111 | Q6HA08 | |
| YLIEQIQSGKEPEVR | 511 | O43520 | |
| PDLAKILEEVRYIAN | 431 | P36544 | |
| QKIEVLVLLPQDDSY | 51 | P17342 | |
| ELRAVDSEYPKNIKV | 441 | P50281 | |
| KGLQRSQILPTEEYE | 166 | Q9NXG6 | |
| KIILVEDLPNQFYRD | 221 | O75943 | |
| GQVYLRKLLDDEQPL | 256 | Q9NS23 | |
| IRPQSIYDAIKEVNL | 256 | Q8WWW0 | |
| AREVQDIVEKYPLEI | 446 | Q9UJ41 | |
| KYPKVQARVQEEIDL | 316 | P24903 | |
| IFVKSLEDPYSQQIR | 926 | Q9NVH2 | |
| VRLEELSDQKNAPYQ | 536 | Q14573 | |
| YPELVLQKTLDRETQ | 191 | Q9Y5F8 | |
| YAELVLNKPLDREEQ | 191 | Q9Y5F3 | |
| VLDEPYEKVVDRIQS | 431 | Q5T2W1 | |
| VPESRVLKYVDTNLQ | 96 | Q9UBU8 | |
| LQQGKRISVPEDVYD | 416 | O00763 | |
| VDEQPVIYKESLALQ | 2801 | Q01484 | |
| EKQEYLLEFEIRNPE | 1341 | Q8N7Z5 | |
| VPAIKSIRVDVQYLD | 116 | Q8NFP4 | |
| VQPEEKKQVEYAVLR | 401 | P0C881 | |
| VQPEEKKQVEYAVLR | 401 | B2RC85 | |
| QPNRVEIYEKTVEVL | 101 | Q7L576 | |
| IQLEKPLDRELQAVY | 3181 | Q14517 | |
| QLLGEEKYRQDLTVP | 411 | Q14296 | |
| LYVTAQDEDQPVLLK | 191 | P01583 | |
| VDQVNDSVYRKVLPA | 566 | Q5VUB5 | |
| NYVEEENIPALKALL | 11 | Q9ULH0 | |
| IIKDERQPFADQSLY | 586 | Q6ZMT4 | |
| IPKEQKYIEEENRLS | 756 | Q6DN14 | |
| KLRSPYAIDNNELLD | 951 | Q6DN14 | |
| LPRYALDEKVAELVQ | 451 | Q8TD91 | |
| LNPIQTDVERIKDTY | 2306 | Q16787 | |
| DVDNKTYLIRLQKPD | 31 | O60524 | |
| RNKTEVDIYNSDPLI | 186 | Q99685 | |
| VEQEEIPRLQALYEK | 141 | Q9H9P8 | |
| LPLNRELVEKVTNEY | 346 | Q4G0N4 | |
| YAPLSRKAQEQIEKE | 981 | Q3B7T1 | |
| IKALLTPEDYQRFLD | 341 | Q9BYM8 | |
| LFQREKVEVQLPELY | 271 | Q14722 | |
| SPDLEVYNVIRKQSE | 286 | Q6UX15 | |
| NEFISKYIVNEPRDV | 256 | Q8N371 | |
| EAAFLNVYKRLIDVP | 86 | Q13948 | |
| IQVAVEELYPNKARA | 11 | Q9C098 | |
| EELYPNKARALTLAQ | 16 | Q9C098 | |
| YQLPSRNLEAVLKED | 1151 | O15055 | |
| DFYDIVLVATPLNRK | 306 | Q9UHG3 | |
| RSYLTEQVNQDLPKE | 611 | Q16822 | |
| SKIQQDPELLAYILE | 161 | Q86V87 | |
| VAALYKREPDSNVIV | 96 | P06858 | |
| VNPLIYTLRNKDVKE | 291 | Q8NHA6 | |
| LLNPIIYSLRNEDVK | 281 | Q8NGD4 | |
| VQIRYSIPEELAKNS | 31 | Q9Y5G2 | |
| KEQVPLVVEEYLDNV | 391 | Q5XG92 | |
| KLLEQDRDIKEPVQY | 91 | Q9H706 | |
| PNLARIDKQETEITY | 116 | Q9BS92 | |
| GQRIDYVLQEKPIES | 656 | O94830 | |
| VVKEPETRYSVLNND | 21 | Q1ED39 | |
| IPVEELAKDQKYRIQ | 371 | P32004 | |
| NIEDAYVAVIRPKNT | 6 | O00522 | |
| LQDVLEETNIPKRLY | 346 | P36776 | |
| DLYDVLAKEPVQRNN | 481 | Q8TDZ2 | |
| PRKGIQAEEILQTYL | 451 | P32455 | |
| YEEPRKGIQAEEILQ | 446 | Q9H0R5 | |
| VEEEQKLPRTLYSQK | 156 | O75023 | |
| ELPDQKQLRYTEELL | 336 | Q92985 | |
| LDVVVYKPLNDSVRA | 506 | Q9P215 | |
| YPELALEKTLDREQQ | 191 | Q9Y5G0 | |
| YPELVLDKALDREEQ | 191 | Q9UN67 | |
| QPNRVEIYEKTVEVL | 101 | Q96F07 | |
| PKVEDLDKDLVNRYT | 56 | Q9C091 | |
| ENPVRAVLYLKELTA | 6 | Q9UPP2 | |
| RNILVEKNYTNSPEE | 286 | Q9P2X3 | |
| RVPENVDAAKELLQY | 591 | A2RRP1 | |
| PDLAKILEEVRYIAN | 341 | Q494W8 | |
| DQVPYVVEKEEQLRK | 676 | Q86Y13 | |
| QYLKSVDIPENRVIL | 116 | Q2TAA2 | |
| RDPDTLLYLLQQKSE | 136 | Q96F24 | |
| VQELLPQYKEREVVN | 81 | P33993 | |
| PQYKEREVVNKDVLD | 86 | P33993 | |
| KVRQEPSEYQDKEVL | 1246 | A2PYH4 | |
| NPFIYSLRNKEVIDA | 286 | P0C628 | |
| PDLTNFTVEELKQRY | 1316 | O94913 | |
| QINAELKPYITEGRI | 251 | Q96HP4 | |
| EYPELVLEKALDREQ | 181 | Q9H158 | |
| NVDRVAEQLEKLGYP | 241 | Q6P988 | |
| EKVQELYAPREVQKA | 236 | Q9H094 | |
| SAKELVEQDIQPARY | 356 | Q9NZ94 | |
| EYIDRIAIPDASKLQ | 71 | O75935 | |
| KYPDLFQVNLEVEVE | 696 | O14976 | |
| QGSLRESVIEEPYQK | 636 | A4FU69 | |
| KALYLQQRPEDETEL | 2966 | Q13315 | |
| APYEQLVRQVEALKA | 6 | O95996 | |
| PESEELIAQYDQIIK | 746 | Q05DH4 | |
| LVDEAKNYLLLPQER | 286 | Q9Y2M5 | |
| ETPEAQRDKLYNVIS | 161 | Q8NHM5 | |
| DEQAPKSRQELIALY | 226 | O15234 | |
| LSRVQDIKYEPQLLA | 66 | Q9BWL3 | |
| EDKQQAALLRPTEVY | 161 | Q9H4Z3 | |
| VIEELEKTYRNDPLQ | 56 | Q96BY6 | |
| EPLDYENVIAQRKTQ | 41 | Q5JSL3 | |
| EAVNEVYKNLIPILE | 1701 | Q96HP0 | |
| SLIGPDQKEYQRELE | 2081 | Q96N67 | |
| LYDLDRIIELNGQKP | 151 | Q49AN0 | |
| AEQYLQEKLPDEVVL | 151 | Q86XK2 | |
| VAAPELLYLRKQAQE | 296 | Q96ST8 | |
| IEQIELRSEKIPEYQ | 311 | Q96JB2 | |
| LRSEKIPEYQQLLND | 316 | Q96JB2 | |
| RQSLEELKPIYEQIC | 91 | Q96HU8 | |
| STQLYEPDRLQELKI | 796 | Q9NX05 | |
| VIAKPLDAEQRSIYN | 1416 | Q8TDW7 | |
| RKPYTKQQIAELENE | 206 | P35452 | |
| LLDNLRNKVIIEYPT | 426 | Q9NWK9 | |
| LPEELLRNLYESIKN | 231 | O43739 | |
| KPYLNRDEEIIKQLQ | 406 | Q8IWF6 | |
| QIYLTDNPEAVAIKL | 376 | Q8NEU8 | |
| IKALQDYSVIEPQIR | 156 | Q86X45 | |
| AESEIQAIRKNYLPI | 2696 | Q0VDD8 | |
| VEQLDQRYLLVPEKV | 216 | Q9Y6V7 | |
| RVPLYIKVLDVNDNA | 471 | P55285 | |
| EKPFYTLRAQAVDIE | 121 | P55289 | |
| SLPKEAARQNYVDLV | 101 | O75521 | |
| PLYRDELVKGLQQEL | 496 | Q8NEL9 | |
| NPVRLYEQLLQKEEE | 551 | Q8NEL9 | |
| RQKQEVYLLPIIISD | 566 | P55286 | |
| AKLNYVPLEKQEEER | 906 | Q7L014 | |
| NTVYRDLKPENILLD | 306 | P34947 | |
| TEEEPSKLLVQNYRA | 251 | Q9ULX7 | |
| NLLKLDPADRYLTEQ | 276 | O76039 | |
| IKNQPRFIESAYDII | 101 | A5D8W1 | |
| LEIQAAYEVLSQPRK | 321 | Q8N4W6 | |
| EYIDPVIDNVLEKNI | 3486 | Q8IVF4 | |
| KYQEEAIPALRDISI | 126 | P57054 | |
| VYAREEVALKINLPE | 66 | O43186 | |
| LILRYQPDQETKTGE | 426 | Q8WY07 | |
| EDPQLTRVLKYFIQA | 391 | B7ZC32 | |
| SLPIEADKYRVALAQ | 56 | A6NMZ7 | |
| LQRDEFIKIPYVQSE | 576 | Q8N4N8 | |
| AIYQKTVESLPNLRE | 351 | Q6UXK5 | |
| QEKNYTIREEIPENV | 56 | Q9BZA8 | |
| QKVEVYLPRFTVEQE | 286 | Q99574 | |
| YPELVLDKALDREEQ | 191 | Q9Y5E1 | |
| NPIIYTLRNAEVKIA | 281 | Q8NGF8 | |
| AYIRILAKIQAADPV | 1371 | Q7Z2Y5 | |
| AKPKEISEIQRLNYE | 306 | Q8NBR6 | |
| SEPNIEDQNRKLTYL | 846 | Q9P2F6 | |
| NPREVTEAKQELITY | 561 | P78332 | |
| VQRVALLLKEQTAYP | 786 | Q8NBS3 | |
| VQPVIDKLAEYVARN | 456 | Q12872 | |
| DLLNRSAPQKLEVIY | 226 | Q6P9F5 | |
| ELNRKVLADLAIYEP | 96 | Q9BYC9 | |
| LKEQERLAYINPDLA | 346 | P31948 | |
| RLAYINPDLALEEKN | 351 | P31948 | |
| LLKFLYDDNQRVEPE | 846 | Q02880 | |
| NIARDIQKIYDKDPL | 121 | Q8IYX1 | |
| PSYGLSREVQEKIEQ | 6 | Q9UI15 | |
| FNYRIDLPNEEVKEL | 731 | O43426 | |
| LEVALKNRQELYALP | 91 | Q9NW38 | |
| KLYDRSLESNPEQLQ | 491 | Q9HCE1 | |
| AVPLYELAVEIRQKS | 1196 | Q7Z494 | |
| PTIEDAYKTQVRIDN | 51 | Q99578 | |
| RNVLELEIKQDYTSP | 541 | Q6P1X5 | |
| TYLAERNKLVVPAVE | 196 | A0PJY2 | |
| DLKLQEYQSAIKVEP | 96 | P37231 | |
| QVQRFLEEEVYPLLK | 456 | P30566 | |
| QYPDLQQDARLKETL | 921 | O94933 | |
| LEQLGIPRQVLKYDD | 201 | Q07960 | |
| EPELLYQNIAERVKE | 751 | Q9H156 | |
| RKQLVIYEEISDPEE | 171 | Q99909 | |
| IQEILNYISRKEFEP | 616 | O15357 | |
| EENKLESLPNEIAYL | 456 | Q9UQ13 | |
| QPEDVNLRVISEYQK | 191 | Q9NR45 | |
| AAYRDLLIKEPQLQS | 536 | Q9C0D5 | |
| LRNEQKIPEEEYIIL | 576 | Q9C0D5 | |
| ELVSFQERIYQKDPV | 696 | Q93073 | |
| LDQLLLPKQSRYEAV | 16 | Q9BV20 | |
| RPTAQDVLETYQKVL | 321 | Q9H5K3 | |
| KQLSEEYERIVNPEK | 251 | O94864 | |
| ILDVLEEIPKNAAYR | 31 | Q16718 | |
| ELPQYEETFRKLQLS | 146 | Q13586 | |
| PVQRVVYNVLSELEK | 101 | Q9H930 | |
| ELVRKPYVLNDLEAE | 86 | Q9Y3C1 | |
| LLNKIYEAQPEISRA | 396 | O60287 | |
| RQLALETIDINKDPY | 31 | Q15428 | |
| NVPVTEENKKEYVRL | 576 | Q9HCE7 | |
| RKQLVIYEEISDPEE | 171 | Q16384 | |
| QIKLQRYPESAEEKV | 1241 | Q8NFU7 | |
| LPEGIQRENNKLYEE | 426 | Q8N3C0 | |
| RDIYDQKLTLQPVDN | 226 | Q15417 | |
| TDPYNDLVKEELNII | 421 | Q9H8M5 | |
| QKLPDLLRSYIDADV | 151 | A5YKK6 | |
| PKLYRSVIEDVINDV | 11 | P52655 | |
| NYIIPNKSEELEARF | 236 | P61812 | |
| AEQLVYLSTELRKQP | 1706 | Q63HN8 | |
| VENIIDIYKQESSRP | 101 | Q9BYV2 | |
| LLEEQLPQYRLKVDT | 46 | O60296 | |
| EITVENLPSYFRLQK | 616 | Q9P2K2 | |
| DLVTSLEQRKEPYNL | 51 | Q3SXZ3 | |
| VENIIDIYKQESTRP | 101 | Q9BYV6 | |
| PKEINLVDDYFELVQ | 336 | P21580 | |
| LENYRVSLAEKVIPA | 646 | P11217 | |
| GNRLKTLPYEEVLEQ | 186 | Q96PX8 | |
| RKQLVIYEEISDPEE | 171 | Q16385 | |
| ITNIEFLPEYRQKES | 116 | Q7RTY8 | |
| TQPYNIREDSILDQK | 586 | Q86WA9 | |
| VETYEKPQVAEALQR | 321 | Q9UHP6 | |
| EDPDQQYLILNTARK | 501 | Q96QK1 | |
| RKQLVVYEEISDPEE | 171 | O60224 | |
| RKQLVIYEEISDPQE | 171 | O60225 | |
| RKQLVIYEEISDPEE | 171 | Q7RTT6 | |
| RKQLVIYEEISDPEE | 171 | Q7RTT5 | |
| RKQLVIYEEISDPEE | 171 | Q7RTT3 | |
| ETDVPQKSRQLYAII | 71 | Q8TAQ9 | |
| NYLRALQLKPDDVIT | 801 | Q8N394 | |
| PVQRVVYNVLSELEK | 101 | P23497 | |
| TYNVRPSEDINLDIK | 571 | Q8IV35 | |
| PQLYELNRDLLKELE | 926 | Q6ZV73 | |
| RKPTQEAYQNELKIE | 1141 | Q6ZV73 | |
| LENYRVSLAEKVIPA | 646 | P11216 | |
| AQETAPAKLIVYLQR | 186 | Q9BU02 | |
| AKEIPRIFQILYANE | 1221 | O75116 | |
| EALELYNKLVNEAPV | 356 | O75886 | |
| FLRPTKENVDYIIQE | 71 | Q9NRW7 | |
| VRTKLETQPQEEYEI | 96 | Q4J6C6 | |
| DSKEYVAAQLRQLPA | 161 | Q14151 | |
| LPLIIREKDTEYQLN | 426 | Q8TEA7 | |
| IPNLRDSLVKILQDY | 736 | P49754 | |
| PQEEVYLSLKEAQLI | 556 | O14512 | |
| RDISTNKVEQIPYGE | 1646 | P49750 | |
| LDLTPNQEYLFERIK | 401 | Q96SK2 | |
| ERKPYIVKNVTDLLN | 476 | O75346 | |
| VLIVNSEYPAERKQA | 601 | O43592 | |
| NRILTLGEVPKDQVY | 811 | Q9UIA9 | |
| KREYIIKLEPIETNQ | 126 | Q2TB10 | |
| VADLLALEEPVDYKQ | 21 | Q9H1V8 | |
| ALYKLAAQENRPVTD | 631 | Q9BTW9 | |
| ELERLPAKDIQTNVY | 211 | P48556 | |
| PSTELAKQVIEYARQ | 331 | P48556 | |
| RTQVYQDLEEKLPTK | 496 | Q9C0D7 | |
| DPLLESVDIRQIYDK | 251 | P28347 | |
| DPVKIALARNNAEVY | 721 | Q96RS0 | |
| PVSLENIQRDYKETA | 431 | Q9BXT5 | |
| PTVEAKLRNQLEKYI | 271 | Q7Z2W7 | |
| QELVSEAYPILEQKL | 461 | Q9HBM0 | |
| AISNPDLVIYLEQRK | 46 | B4DXR9 | |
| KRLLSYINEEPLDAN | 656 | Q6ZXV5 | |
| NPTIVQEYTKREEEI | 886 | Q8IY18 | |
| NNKIISLDLPVAEVY | 4411 | Q5T4S7 | |
| LENYRVSLAEKVIPA | 646 | P06737 | |
| LQRETAFLKQADYVP | 36 | P01266 | |
| DPAQKILYRDVILEN | 26 | Q8NDW4 | |
| VPFKVSDLRNQVYLE | 281 | Q5T124 | |
| RLAEPDIYQEKLSQV | 1226 | Q70EL1 | |
| EPISEKQYLAAEQLL | 636 | Q7Z570 | |
| LPEGLYAQDKVVRNE | 481 | Q9H7M6 | |
| LKPELARQEYNDIQL | 486 | P23276 | |
| NIRLIGIPEKESYEN | 701 | Q5T7N2 | |
| QRITEELQKYGVDIP | 351 | P20591 | |
| KVLNLYTPVNEFEER | 1781 | Q9Y4I1 | |
| INTKSDVQEAIPYRV | 1056 | Q86UW6 | |
| ELPEKQEQLAAIYAV | 1796 | Q13459 | |
| PISNDDLLVVEKYQR | 556 | Q9NZM1 |